<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Intensive care unit management of the intubated post-cardiac arrest adult patient
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Intensive care unit management of the intubated post-cardiac arrest adult patient
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Intensive care unit management of the intubated post-cardiac arrest adult patient
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Paul N Fiorilli, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Daniel M Kolansky, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Scott Manaker, MD, PhD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Geraldine Finlay, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jul 13, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H285016788">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         An estimated 350,000 people present with out-of-hospital cardiac arrest in the United States each year [
         <a href="#rid1">
          1
         </a>
         ]. Survival rates for out-of-hospital cardiac arrest are extremely poor but have improved with resuscitation measures and aggressive supportive care in the intensive care unit (ICU).
        </p>
        <p>
         The management of patients in the ICU following cardiac arrest will be reviewed here. Our approach is in keeping with the European Resuscitation Council and European Society of Intensive Care Medicine [
         <a href="#rid2">
          2,3
         </a>
         ]. Cardiopulmonary resuscitation, post-cardiac arrest management in the emergency department, and cardiac evaluation in survivors of cardiac arrest are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/272.html" rel="external">
          "Adult basic life support (BLS) for health care providers"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/278.html" rel="external">
          "Advanced cardiac life support (ACLS) in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/13838.html" rel="external">
          "Initial assessment and management of the adult post-cardiac arrest patient"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/970.html" rel="external">
          "Cardiac evaluation of the survivor of sudden cardiac arrest"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H199519376">
         <span class="h1">
          INITIAL ASSESSMENT IN THE INTENSIVE CARE UNIT
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients who arrive to the ICU with return of spontaneous circulation (ROSC) following sudden cardiac arrest (SCA), initial assessment is focused on assessing the etiology and complications of SCA  (
         <a class="graphic graphic_table graphicRef70060" href="/z/d/graphic/70060.html" rel="external">
          table 1
         </a>
         and
         <a class="graphic graphic_table graphicRef52416" href="/z/d/graphic/52416.html" rel="external">
          table 2
         </a>
         ) and providing care that ensures continued hemodynamic stability. We encourage a multidisciplinary approach to management.
        </p>
        <p class="headingAnchor" id="H3473002913">
         <span class="h2">
          Immediate post-cardiac arrest assessment and testing
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Brief physical assessment
         </strong>
         – On arrival to the ICU, vital signs are recorded. We briefly examine for an elevated jugular venous pressure, abnormal heart and lung sounds, and burns and wounds. We also assess airway devices, intravascular catheters, and other support devices (eg, pacemaker, intra-aortic balloon pump [IABP]) that may have been placed during the arrest. We examine the abdomen for bowel sounds, masses, and tenderness, and lower extremities are examined for pulses and for signs of deep venous thrombosis and venipuncture or intraosseous (IO) cannulation sites. We perform a brief neurologic assessment of mental status, response to verbal commands, presence or absence of purposeful motor movements, and pupillary reaction to light.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Fluid status assessment
         </strong>
         – In general, many patients are already receiving post-resuscitation fluids and vasopressors, which should be continued or stopped depending on the evaluation of their volume status. Hemodynamic goals are discussed below. (See
         <a class="local">
          'Hemodynamic monitoring and goals'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Device assessment
         </strong>
         – Most patients already have intravenous and/or IO access, and we assess the need for peripheral or central venous catheter placement. Occasionally, patients have an IABP in place, are on extracorporeal membrane oxygenation (ECMO), or have a pericardial drain or temporary pacemaker in place; we make note of the settings and ensure proper function of such devices. If not already in place, we plan for targeted temperature management, if indicated. (See
         <a class="local">
          'Active temperature control'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/1482.html" rel="external">
          "Intraaortic balloon pump counterpulsation"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/13823.html" rel="external">
          "Emergency pericardiocentesis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1625.html" rel="external">
          "Extracorporeal life support in adults in the intensive care unit: Overview"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Testing
         </strong>
         – If not already obtained in the emergency department (ED), we obtain an electrocardiogram (ECG), a chest radiograph, complete blood count, troponin I or T, brain natriuretic peptide (BNP; or N-terminal BNP), routine chemistries including phosphate, magnesium, calcium, coagulation studies, liver function tests, and arterial blood gases. Bedside echocardiography or point of care ultrasound may also be performed.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Other tests that may be obtained depend upon the suspicion for select etiologies and include blood cultures and urinalysis (when infection is suspected), urine and serum toxicology screen (when drug overdose is suspected), and computed tomography (CT) of the brain, chest, and/or abdomen (if trauma is suspected).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Subspecialty consultations
         </strong>
         – Evaluation and management of SCA is multidisciplinary. We consult appropriate subspecialty clinicians early in the course of patients who present with SCA so that the approach involves a well-balanced team (eg, pulmonary, cardiology, neurology, intensivist). This is particularly important for implementing early intervention and for prognostication for both cardiac and non-cardiac reasons for SCA.
        </p>
        <p>
        </p>
        <p>
         Further details regarding the immediate post-cardiac arrest assessment in the ED and the assessment by cardiologists for cardiac etiologies associated with SCA are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/970.html" rel="external">
          "Cardiac evaluation of the survivor of sudden cardiac arrest", section on 'Initial evaluation'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/13838.html" rel="external">
          "Initial assessment and management of the adult post-cardiac arrest patient", section on 'Identifying and treating reversible causes of cardiac arrest'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3250830230">
         <span class="h2">
          Reassessment of cardiac arrest etiology
         </span>
         <span class="headingEndMark">
          —
         </span>
         Following admission to the ICU, a key first step is the
         <strong>
          re
         </strong>
         -evaluation of the etiology of SCA.
        </p>
        <p>
         The majority of sudden death cases are cardiac in etiology; however, approximately 15 to 25 percent of cases are not  (
         <a class="graphic graphic_table graphicRef70060" href="/z/d/graphic/70060.html" rel="external">
          table 1
         </a>
         and
         <a class="graphic graphic_table graphicRef52416" href="/z/d/graphic/52416.html" rel="external">
          table 2
         </a>
         ) [
         <a href="#rid4">
          4-7
         </a>
         ]. At the time of initial presentation, collateral information is often not available; however, there is usually more time to gather this information while the patient is in the ICU. Re-evaluation involves retaking the history from witnesses (if available) and family or friends and re-reviewing the records of the first responders and emergency department as well as re-reviewing electrocardiographic, radiographic, and laboratory studies. In some cases, when the etiology is unclear or CPR-related trauma is suspected, cross sectional head-to-pelvis CT is performed [
         <a href="#rid8">
          8,9
         </a>
         ], although this is not routine.
        </p>
        <p>
         The evaluation of patients for the etiology and complications of cardiac arrest is discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/974.html" rel="external">
          "Pathophysiology and etiology of sudden cardiac arrest", section on 'Etiology of SCD'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/13854.html" rel="external">
          "Initial management of trauma in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/98976.html" rel="external">
          "Evaluation of and initial approach to the adult patient with undifferentiated hypotension and shock"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/970.html" rel="external">
          "Cardiac evaluation of the survivor of sudden cardiac arrest"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1917972076">
         <span class="h2">
          Hemodynamic monitoring and goals
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients after cardiac arrest often have vasodilatory hypotension, necessitating vasopressors and fluid management. We suggest maintaining a systolic blood pressure of 90 mmHg and a mean arterial pressure (MAP) goal of 65 mmHg during the post-arrest period. Use of vasopressors may be needed to achieve these goals but higher spontaneous values do not necessarily need to be lowered to these targets.
        </p>
        <p>
         This approach is based upon observational studies that suggest that a systolic blood pressure of less than 90 mmHg was associated with worse mortality [
         <a href="#rid10">
          10-12
         </a>
         ]. Several studies that have evaluated bundles of care that included a MAP goal of 65 to 80 mmHg have also demonstrated an improvement in survival [
         <a href="#rid13">
          13,14
         </a>
         ]. Targeting a MAP &gt;65 mmHg may not have any added benefit. This was evidenced by a randomized trial of 789 cardiac arrest survivors that demonstrated the composite outcome of death and severe disability or coma at discharge was no different among patients in whom a MAP of 63 mmHg was targeted compared with MAP of 77 mmHg [
         <a href="#rid15">
          15
         </a>
         ]. These results may be impacted by the lower-than-expected difference in blood pressure between the groups and loss to follow up.
        </p>
        <p>
         We prefer
         <a class="drug drug_general" data-topicid="9709" href="/z/d/drug information/9709.html" rel="external">
          norepinephrine
         </a>
         as the first-line vasopressor when hypotension is present. While there are limited data in patients with cardiogenic shock that suggest there is no difference in mortality when norepinephrine is used as compared to
         <a class="drug drug_general" data-topicid="9384" href="/z/d/drug information/9384.html" rel="external">
          dopamine
         </a>
         [
         <a href="#rid16">
          16
         </a>
         ], other studies have suggested that dopamine may be associated with harm due to an increased risk of arrhythmia and possible increased risk of death when compared with norepinephrine [
         <a href="#rid17">
          17
         </a>
         ]. When cardiogenic shock is present, we assess the need for mechanical support (eg, intra-aortic balloon pump, ventricular assist device), inotropic support (eg,
         <a class="drug drug_general" data-topicid="9380" href="/z/d/drug information/9380.html" rel="external">
          dobutamine
         </a>
         2 to 15 mcg/kg/minute or
         <a class="drug drug_general" data-topicid="9652" href="/z/d/drug information/9652.html" rel="external">
          milrinone
         </a>
         0.125 to 0.5 mcg/kg/minute), and in cases of refractory shock, extracorporeal membrane oxygenation (usually venoarterial ECMO). (See
         <a class="medical medical_review" href="/z/d/html/83.html" rel="external">
          "Prognosis and treatment of cardiogenic shock complicating acute myocardial infarction"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/134279.html" rel="external">
          "Extracorporeal life support in adults: Management of venoarterial extracorporeal membrane oxygenation (V-A ECMO)"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/134279.html" rel="external">
          "Extracorporeal life support in adults: Management of venoarterial extracorporeal membrane oxygenation (V-A ECMO)", section on 'Refractory cardiogenic shock'
         </a>
         .)
        </p>
        <p>
         Aggressive fluid resuscitation is generally performed during the cardiac arrest. In the post-cardiac arrest period, we prefer to avoid over-resuscitation and maintain euvolemia. In some cases, diuresis may be needed with loop diuretics to achieve this goal.
        </p>
        <p>
         Hypotension should resolve within 48 to 72 hours. For those with persistent hypotension, we assess patients for possible sepsis or cardiomyopathy. (See
         <a class="medical medical_review" href="/z/d/html/1613.html" rel="external">
          "Evaluation and management of suspected sepsis and septic shock in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/44.html" rel="external">
          "Clinical manifestations and diagnosis of cardiogenic shock in acute myocardial infarction"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/98976.html" rel="external">
          "Evaluation of and initial approach to the adult patient with undifferentiated hypotension and shock"
         </a>
         .)
        </p>
        <p>
         A pulmonary artery catheter is rarely necessary but may be indicated when patients remain hypotensive and fluid status is uncertain. The value of other novel dynamic hemodynamic monitoring tools in this population is unknown. (See
         <a class="medical medical_review" href="/z/d/html/1593.html" rel="external">
          "Pulmonary artery catheterization: Indications, contraindications, and complications in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1595.html" rel="external">
          "Pulmonary artery catheterization: Interpretation of hemodynamic values and waveforms in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/107337.html" rel="external">
          "Novel tools for hemodynamic monitoring in critically ill patients with shock"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4258145549">
         <span class="h2">
          Assessing the need for immediate coronary revascularization
         </span>
         <span class="headingEndMark">
          —
         </span>
         The approach varies depending upon the etiology for SCA.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Patients with non-cardiac etiology for SCA
         </strong>
         – For patients who have a clear non-cardiac cause for SCA (eg, acute pulmonary embolism or drug overdose), angiography is not typically necessary.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Patients with likely cardiac etiology for SCA
         </strong>
         – In patients with a
         <strong>
          cardiac
         </strong>
         etiology for SCA, ECG, bedside echocardiography, and consultation with a cardiologist are typically performed to define the need for coronary revascularization.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Patients with
         </strong>
         <strong>
          ST segment elevation myocardial infarction (STEMI) or new left bundle branch block (LBBB)
         </strong>
         – For patients with ECG findings consistent with STEMI or new LBBB who are without contraindications, we perform emergency coronary angiography with intent to revascularize. We prefer percutaneous coronary intervention, if feasible, but medical reperfusion therapy is acceptable if catheterization is not available and no contraindications are present. (See
         <a class="medical medical_review" href="/z/d/html/970.html" rel="external">
          "Cardiac evaluation of the survivor of sudden cardiac arrest", section on 'Coronary angiography'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/55.html" rel="external">
          "Acute ST-elevation myocardial infarction: The use of fibrinolytic therapy"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Patients with potential cardiac etiology for SCA but without STEMI
         </strong>
         – In patients with cardiac arrest but
         <strong>
          without
         </strong>
         STEMI on their ECG, practice and opinion vary in regard to whether coronary angiography should be performed early (immediately) or be delayed (within days, or following discharge). We believe that coronary angiography can safely be delayed in many patients without STEMI on ECG. However, there may be a role for early angiography in select patients. (See
         <a class="local">
          'Ongoing assessment of the need for revascularization'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         We have a low threshold to perform early angiography in patients with the following:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Known pre-existing coronary artery disease
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Evidence of recurrent ischemia
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Electrical or hemodynamic instability
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Witness-reported chest pain prior to SCA
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         If coronary angiography was not performed early after cardiac arrest, we consider proceeding with delayed coronary angiography in patients with the following:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Unexplained cardiac arrest
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Left ventricular dysfunction
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Recurrent symptoms after recovery from cardiac arrest
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Inducible ischemia on a stress test
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Planned placement of an intracardiac defibrillator
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Early data describing outcomes when early angiography is performed in patients with SCA without ST elevation on ECG suggested there may be benefit to this approach, although newer evidence, including two randomized trials, does not generally support early angiography.
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Evidence in favor of early catheterization was derived from older observational studies that report the identification of significant coronary lesions in up to a third of patients with SCA without ST elevation on ECG [
         <a href="#rid18">
          18-20
         </a>
         ] and a potential survival benefit from intervention [
         <a href="#rid21">
          21,22
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         However, newer evidence does not support early angiography in this population. In a randomized trial of 552 patients without STEMI on initial ECG post-cardiac arrest (COACT), there was no significant difference in survival at 90 days [
         <a href="#rid23">
          23
         </a>
         ] or at one year [
         <a href="#rid24">
          24
         </a>
         ] between an immediate angiography strategy (median time 2.3 hours) and delayed angiography strategy (median time 121.9 hours). In a second randomized trial of 554 patients with successfully resuscitated out-of-hospital cardiac arrest without ST-segment elevation present (TOMAHAWK), a strategy of immediate coronary angiography as compared with delayed or selective angiography provided no benefit with respect to the 30-day risk of death from any cause [
         <a href="#rid25">
          25
         </a>
         ]. In a meta-analysis of 11 studies that included the COACT randomized trial, there was no difference in 30-day mortality or neurologic outcomes between early or late angiography [
         <a href="#rid26">
          26
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3591947517">
         <span class="h2">
          Assess need for other immediate interventions
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients who do not need coronary revascularization, we assess whether other immediate interventions or therapies are needed, such as the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A pericardial drain (for cardiac tamponade) (see
         <a class="medical medical_review" href="/z/d/html/143123.html" rel="external">
          "Pericardial effusion: Approach to management", section on 'Indications for pericardial fluid removal'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A temporary pacemaker (for heart block or bradycardia) (see
         <a class="medical medical_review" href="/z/d/html/1005.html" rel="external">
          "Temporary cardiac pacing"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Bronchodilators (for bronchospasm due to exacerbation of chronic obstructive pulmonary disease [COPD] or asthma) (see
         <a class="medical medical_review" href="/z/d/html/1461.html" rel="external">
          "COPD exacerbations: Management", section on 'Initial pharmacologic therapy'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Chest tube (for pneumothorax) (see
         <a class="medical medical_review" href="/z/d/html/126623.html" rel="external">
          "Thoracostomy tubes and catheters: Placement techniques and complications"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Intravenous (IV) fluids and antibiotics (for sepsis) (see
         <a class="medical medical_review" href="/z/d/html/1613.html" rel="external">
          "Evaluation and management of suspected sepsis and septic shock in adults"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Thrombolytic therapy and/or anticoagulation (for pulmonary embolism) (see
         <a class="medical medical_review" href="/z/d/html/8265.html" rel="external">
          "Treatment, prognosis, and follow-up of acute pulmonary embolism in adults"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Electrolyte replacement (for electrolyte disturbances)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H114652311">
         <span class="h1">
          GENERAL CRITICAL CARE MANAGEMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most patients who survive sudden cardiac arrest (SCA) are intubated and require mechanical ventilation.
        </p>
        <p class="headingAnchor" id="H3295849679">
         <span class="h2">
          General supportive care
         </span>
         <span class="headingEndMark">
          —
         </span>
         Supportive care for patients in the ICU is typically bundled. Bundled care is associated with improved outcomes and involves the following [
         <a href="#rid27">
          27-29
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Ventilator-associated pneumonia precautions (eg, elevating the head of the bed to 30 degrees, mouth care). (See
         <a class="medical medical_review" href="/z/d/html/1659.html" rel="external">
          "Evaluation and management of elevated intracranial pressure in adults", section on 'Position'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6995.html" rel="external">
          "Risk factors and prevention of hospital-acquired and ventilator-associated pneumonia in adults", section on 'Preventing aspiration'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Stress ulcer prophylaxis. (See
         <a class="medical medical_review" href="/z/d/html/1611.html" rel="external">
          "Stress ulcers in the intensive care unit: Diagnosis, management, and prevention"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Venous thromboembolism (VTE) prophylaxis. (See
         <a class="medical medical_review" href="/z/d/html/1346.html" rel="external">
          "Prevention of venous thromboembolic disease in acutely ill hospitalized medical adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Early physical and occupational therapy. (See
         <a class="medical medical_review" href="/z/d/html/140399.html" rel="external">
          "Post-intensive care syndrome (PICS): Treatment and prognosis", section on 'Early ambulation/physical therapy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Early nutrition (not initiated during therapeutic hypothermia [TH] due to reduced bowel motility). (See
         <a class="medical medical_review" href="/z/d/html/1617.html" rel="external">
          "Nutrition support in intubated critically ill adult patients: Initial evaluation and prescription"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Glycemic control. (See
         <a class="medical medical_review" href="/z/d/html/1600.html" rel="external">
          "Glycemic control in critically ill adult and pediatric patients"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The target blood glucose is similar to that in critically ill patients without SCA (ie, between 140 and 180 mg/dL [7.8 and 10 mmol/L]). Data to support this approach are based upon studies in patients with SCA that demonstrate worse outcomes in this population with hyperglycemia [
         <a href="#rid30">
          30-32
         </a>
         ] as well as data that report no benefit and possible harm from hypoglycemia when strict glucose targets (70 to 108 mg/dL; 3.9 to 6 mmol/L) are compared with more liberal strategies (108 to 144 mg/dL; 6 to 8.1 mmol/L) [
         <a href="#rid33">
          33-36
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Infection prevention measures to prevent skin (eg, frequent turning) and urinary tract infections (eg, early urinary catheter removal).
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3262398353">
         <span class="h2">
          Airway, ventilation, and oxygen targets
         </span>
         <span class="headingEndMark">
          —
         </span>
         If a temporizing rescue airway device (eg, laryngeal mask) was used during the initial resuscitation, we switch to a more definitive airway (eg, endotracheal tube). Intubation and airway management are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/276.html" rel="external">
          "Overview of advanced airway management in adults for emergency medicine and critical care"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/267.html" rel="external">
          "Basic airway management in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/270.html" rel="external">
          "Rapid sequence intubation in adults for emergency medicine and critical care"
         </a>
         .)
        </p>
        <p>
         There is no optimal mode of ventilation for this population. We typically use a volume-limited assist control mode using initial settings outlined in the table  (
         <a class="graphic graphic_table graphicRef123028" href="/z/d/graphic/123028.html" rel="external">
          table 3
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/1640.html" rel="external">
          "Overview of initiating invasive mechanical ventilation in adults in the intensive care unit"
         </a>
         .)
        </p>
        <p>
         We obtain arterial blood gas measurements after the body temperature has dropped significantly during TH (eg, 33°C) since hypothermia decreases the minute ventilation and also affects blood gas interpretation. In post-cardiac arrest patients (including those receiving hypothermia), we typically use the following target ventilation and oxygenation strategies:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         We target an arterial carbon dioxide tension (PaCO
         <sub>
          2
         </sub>
         ) of approximately 40 mmHg (or end-tidal CO
         <sub>
          2
         </sub>
         of approximately 35 mmHg). This recommendation is based upon data that suggest that maintaining a PaCO
         <sub>
          2
         </sub>
         in a normal range (35 to 45 mmHg) is associated with improved outcomes in patients with SCA [
         <a href="#rid37">
          37,38
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The exception is patients with chronic hypercapnia (eg, chronic obstructive pulmonary disease) who require ventilator adjustments to achieve prehospitalization PaCO
         <sub>
          2
         </sub>
         values. Hyperventilation should also be avoided since a low PaCO
         <sub>
          2
         </sub>
         can lead to cerebral vasoconstriction [
         <a href="#rid39">
          39,40
         </a>
         ] as well as a reduction in preload and a decrease in cardiac output and coronary perfusion pressure [
         <a href="#rid41">
          41
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         When a patient's core temperature is 33°C, the patient's actual PaCO
         <sub>
          2
         </sub>
         may be 6 to 7 mmHg lower than the value reported by the blood gas machine [
         <a href="#rid42">
          42
         </a>
         ]. We suggest targeting slightly higher PaCO
         <sub>
          2
         </sub>
         values in order to avoid unintended hyperventilation and the resulting cerebral vasoconstriction.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         There continues to be ongoing research in this area. Preliminary data suggest that mild hypercapnia may have a potential benefit by the induction of cerebral vasodilation and improved cerebral saturation [
         <a href="#rid43">
          43-45
         </a>
         ]. Despite these data, one large randomized trial of 1700 patients with SCA reported no difference in neurologic outcome or survival in patients who were ventilated to maintain a normal PaCO
         <sub>
          2
         </sub>
         of 35 to 45 mmHg compared with patients who were ventilated to maintain a PaCO
         <sub>
          2
         </sub>
         between 50 and 55 mmHg [
         <a href="#rid46">
          46
         </a>
         ]. In addition, there were no significant group differences in the occurrence of myoclonic and tonic-clonic seizures.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         We target a peripheral oxygen saturation (SpO
         <sub>
          2
         </sub>
         ) between 94 and 96 percent and an arterial oxygen tension (PaO
         <sub>
          2
         </sub>
         ) between 65 and 100 mmHg. Hyperoxia (eg, PaO
         <sub>
          2
         </sub>
         &gt;100 mmHg) and hypoxemia (eg, PaO
         <sub>
          2
         </sub>
         &lt;65 mmHg) should both be avoided. Hypoxemia may aggravate cerebral edema and hyperoxia has been shown to be associated with an increased mortality [
         <a href="#rid47">
          47
         </a>
         ]. The lower end of this range is supported by an open-label randomized trial of 789 cardiac arrest survivors that demonstrated the composite outcome of death and severe disability or coma at discharge was no different among patients in whom a liberal oxygen level (PaO
         <sub>
          2
         </sub>
         98 to 105 mmHg [13 to 14 kPa]) was targeted compared with a restrictive oxygen target (PaO
         <sub>
          2
         </sub>
         68 to 75 mmHg [9 to 10 kPa]) [
         <a href="#rid48">
          48
         </a>
         ]. These results may have been impacted by loss to follow up and higher-than-expected spontaneous oxygenation in the restrictive strategy group.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         At a core temperature of 33°C, the PaO
         <sub>
          2
         </sub>
         reported by the laboratory may be higher than the patient's actual PaO
         <sub>
          2
         </sub>
         . Thus, in this clinical setting, maintaining a laboratory PaO
         <sub>
          2
         </sub>
         between 70 and 120 mmHg is reasonable.
        </p>
        <p>
        </p>
        <p>
         Oxygen targets prior to ICU admission are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/13838.html" rel="external">
          "Initial assessment and management of the adult post-cardiac arrest patient", section on 'Respiratory considerations'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2809656075">
         <span class="h2">
          Transfusions
         </span>
         <span class="headingEndMark">
          —
         </span>
         We do not routinely calculate oxygen delivery and do not advocate red blood cell transfusion to a normal hematocrit given the prothrombotic state seen in patients with SCA. Failure of the serum lactate to clear over time suggests inadequate perfusion and prompts us to re-evaluate all aspects of oxygen delivery:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cardiac output
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Intravascular volume
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hemoglobin concentration
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Blood pressure
        </p>
        <p>
        </p>
        <p>
         Transfusion parameters in critically ill patients including those with cardiac ischemia are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/1615.html" rel="external">
          "Use of blood products in the critically ill", section on 'RBC indications'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7948.html" rel="external">
          "Indications and hemoglobin thresholds for RBC transfusion in adults", section on 'Acute MI'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4134344830">
         <span class="h2">
          Antibiotic therapy and prophylaxis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Despite the development of pneumonia in many patients following SCA, we suggest not administering prophylactic antibiotic therapy routinely in this patient population. We typically limit administration of antibiotics to patients with evidence of infection (eg, sepsis).
        </p>
        <p>
         While early retrospective studies have suggested a possible reduction in pneumonia in patients with SCA treated with antibiotics [
         <a href="#rid49">
          49
         </a>
         ], a meta-analysis of 11 studies (three randomized trials and eight observational studies) reported that antibiotic prophylaxis in this population was not associated with a reduction in the incidence of pneumonia, survival, or ICU length of stay [
         <a href="#rid50">
          50
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6993.html" rel="external">
          "Treatment of hospital-acquired and ventilator-associated pneumonia in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2518569062">
         <span class="h2">
          Early discussion of the patient's wishes
         </span>
         <span class="headingEndMark">
          —
         </span>
         We advise that the patient's wishes and goals of care be established early. Many patients with SCA are intubated and sedated and/or have hypoxic encephalopathy and are, therefore, unable to participate in a goal-of-care discussion. Thus, we hold family meetings early and frequently (eg, daily) to obtain an appropriate plan of care that is consistent with the patient's wishes. Involving the palliative care team on day one of ICU admission is prudent given the poor outcome for many of these patients. Key components of holding a successful family meeting are provided separately. (See
         <a class="medical medical_review" href="/z/d/html/1643.html" rel="external">
          "Communication in the ICU: Holding a meeting with families and caregivers"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/83235.html" rel="external">
          "Palliative care: Issues in the intensive care unit in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1804960877">
         <span class="h1">
          ACTIVE TEMPERATURE CONTROL
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients who achieve return of spontaneous circulation and do
         <strong>
          not
         </strong>
         initially have purposeful neurologic activity on examination (eg, responding appropriately to verbal commands, withdrawing to painful stimuli), we perform active temperature control (ATC) regardless of initial rhythm or location of arrest. In most patients, ATC is begun in the emergency department and continued in the ICU. However, for patents who are quickly admitted to the ICU from the emergency department or who experience sudden cardiac arrest (SCA) on the floor or other parts of the hospital, ATC is often begun and maintained in the ICU. The rationale for ATC following SCA is based upon the observation that fever is harmful [
         <a href="#rid51">
          51-55
         </a>
         ] and that ATC improves survival and neurologic outcome in this population. The optimal temperature is unknown and ranges from 32 to 37.5°C, the details of which are discussed below. (See
         <a class="local">
          'Setting the target temperature'
         </a>
         below.)
        </p>
        <p>
         Further details regarding the indications and contraindications for the initiation of ATC after cardiac arrest are reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/13838.html" rel="external">
          "Initial assessment and management of the adult post-cardiac arrest patient", section on 'Indications and contraindications'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2854837097">
         <span class="h2">
          Phases
         </span>
         <span class="headingEndMark">
          —
         </span>
         ATC consists of three phases:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         An initiation phase, which should be started as soon as possible after return of spontaneous circulation (ROSC) and often begun in the emergency department (ED) (see
         <a class="local">
          'Initiation'
         </a>
         below)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A maintenance phase, which lasts for a minimum of 24 hours (see
         <a class="local">
          'Maintenance'
         </a>
         below)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A rewarming phase (see
         <a class="local">
          'Rewarming'
         </a>
         below)
        </p>
        <p>
        </p>
        <p>
         In general, central venous or arterial access is warranted since multiple laboratory draws are needed during ATC to monitor for adverse effects.
        </p>
        <p class="headingAnchor" id="H1008787127">
         <span class="h3">
          Initiation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Establishing ATC involves selecting a method for temperature control, setting a target temperature, and applying it as soon as possible.
        </p>
        <p class="headingAnchor" id="H987283857">
         <span class="h4">
          Devices
         </span>
         <span class="headingEndMark">
          —
         </span>
         A cooling device with an automated feedback mechanism is necessary to actively control patient temperature. There are several commercially available devices. Each institution typically selects their own device so it is prudent that clinicians and healthcare staff be educated regarding its use. Institutions should utilize a cooling technique that is feasible to consistently deploy based on resources and equipment availability.
        </p>
        <p>
         Techniques for ATC include the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Surface methods such as water and/or air-circulating blankets and water-circulating gel-coated pads. This is generally the most common approach.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Intravascular methods such as an intravascular cooling catheter.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Rapid infusion of cold
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         and ice packs may be used in an emergency setting when automated cooling devices are not available and the patient needs transport to a facility that has ATC capability.
        </p>
        <p>
        </p>
        <p>
         There is insufficient evidence to recommend one cooling modality over another [
         <a href="#rid56">
          56-58
         </a>
         ], although some data suggest that intravascular and surface cooling methods are no different in terms of neurologic outcomes and survival. Surface cooling methods (eg, cooling blankets) are more commonly used in ICUs than intravascular cooling methods. We typically use a surface cooling device. In general, surface cooling methods can often achieve desired temperatures quickly and effectively since many patients are already mildly hypothermic (35 to 35.5°C) from the mixing of cooler peripheral blood with core blood during resuscitation.
        </p>
        <p class="headingAnchor" id="H1286775785">
         <span class="h4">
          Setting the target temperature
         </span>
         <span class="headingEndMark">
          —
         </span>
         For most patients managed with ATC following cardiac arrest, we suggest, for the first 24 hours, controlling the core body temperature to either a target between 33 and 36°C (also known as therapeutic hypothermia [TH]) or between 36.5 and 37.5°C (ie, targeted normothermia); both approaches should be coupled with proactive avoidance of fever (eg, ≥37.5°C) for an additional 24 to 48 hours after discontinuation of ATC (see
         <a class="local">
          'Rewarming'
         </a>
         below). While there is no universal optimal target temperature, patient-specific factors may influence whether the lower or upper end of the target range between 33 and 37.5°C is selected. For example:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A target temperature on the higher end of this range (eg, 36.0 to 37.5°C; ie, maintenance of normothermia) may be appropriate for patients with mild brain injury, higher bleeding risk, trauma, recent surgery, septic shock, or patients with severe underlying comorbid medical conditions since the risks of bleeding, arrhythmias, and electrolyte disturbances are lower at this temperature compared with TH.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients who may benefit from a temperature target on the lower end of this range (eg, 33 to 36°C; ie, TH) include patients with stroke [
         <a href="#rid59">
          59,60
         </a>
         ], severe brain injury (eg, loss of motor response or brainstem reflexes, malignant EEG patterns [
         <a href="#rid61">
          61
         </a>
         ], or early CT scan changes suggesting the development of cerebral edema) [
         <a href="#rid61">
          61-63
         </a>
         ], subarachnoid hemorrhage [
         <a href="#rid64">
          64
         </a>
         ], or hepatic encephalopathy [
         <a href="#rid65">
          65,66
         </a>
         ]. In these patients, a greater degree of hypothermia may help reduce cerebral edema and seizure activity.
        </p>
        <p>
        </p>
        <p>
         Data that describe the impact of different ATC strategies include the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          TH versus no ATC
         </strong>
         – Early trials used a target temperature of 32 to 34°C (ie, TH) and demonstrated benefit with TH in this range compared with standard care
         <strong>
          without
         </strong>
         ATC [
         <a href="#rid51">
          51,67
         </a>
         ]. These data are discussed below. (See
         <a class="local">
          'Efficacy'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          TH versus normothermia
         </strong>
         – By contrast, subsequent trials and meta-analyses comparing TH (32 to 33°C) with targeted normothermia (36 to 37.8°C) found similar outcomes between these strategies [
         <a href="#rid68">
          68-72
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In one trial (TTM trial), 939 patients with out-of-hospital cardiac arrest (ventricular fibrillation [VF] or pulseless ventricular tachycardia [VT] in 78 percent) were randomized to ATC targeting a temperature of 33 or 36°C [
         <a href="#rid68">
          68
         </a>
         ]. At six months, the number of patients who had died or had poor neurologic outcome was similar in both groups (54 percent in the 33°C group versus 52 percent in the 36°C group; risk ratio [RR] 1.02, 95% CI 0.88-1.16). The findings were consistent irrespective of age, initial cardiac rhythm, time to return of spontaneous circulation, or scale used for neurologic assessment.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Similarly, a subsequent trial (TTM 2) of 1850 adults with out-of-hospital cardiac arrest also showed no six-month mortality benefit when targeted hypothermia (33°C) was compared with targeted normothermia (≤37.8°C) (50 percent [TH] versus 48 percent [normothermia]) [
         <a href="#rid70">
          70
         </a>
         ]. In addition, the proportion of patients with moderate to severe disability following SCA, as measured by a modified Rankin score ≥4, was also no different (55 percent each). The lack of benefit was consistent across subgroups including sex, age, initial cardiac rhythm, time to return of spontaneous circulation, and presence or absence of shock on admission. Arrhythmia and hemodynamic compromise were more common with patients treated with TH (24 versus 17 percent). The baseline severity of brain injury of included patients appeared to be mild in this study. Whether targeted normothermia is as effective in subgroups with more severe injury is unknown. A metanalysis of TTM and TTM 2 data showed a similar lack of six-month mortality benefit [
         <a href="#rid71">
          71
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         One network meta-analysis of 10 randomized trials (4218 patients) examined the efficacy and safety of deep hypothermia (31 to 32°C), moderate hypothermia (33 to 34°C), mild hypothermia (35 to 36°C), and normothermia (37 to 37.8°C) during ATC [
         <a href="#rid73">
          73
         </a>
         ]. No difference in survival was reported when hypothermic strategies were compared with maintenance of normothermia (low certainty of the effect): deep hypothermia (odds ratio [OR] 1.30, 95% CI 0.73-2.30), moderate hypothermia (OR 1.34, 95% CI 0.92-1.94), mild hypothermia (OR 1.44, 95% CI 0.74-2.80). However, compared with normothermia, the incidence of arrhythmia was higher with moderate and deep hypothermia (OR 1.45, 95% CI 1.08-1.94 and OR 3.58, 95% CI 1.77-7.26), respectively. Other meta-analyses have shown similar results [
         <a href="#rid71">
          71,72,74
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Two levels of TH
         </strong>
         – Another randomized trial (CAPITAL CHILL) found no difference in outcomes when two target levels of TH were compared [
         <a href="#rid75">
          75
         </a>
         ]. In this study, 733 comatose patients were randomly assigned to receive TH with a target of 31 or 34°C for 24 hours after cardiac arrest. No difference was reported in either mortality or neurologic outcomes, although ICU length of stay was longer in those who received 31°C. The study may have been underpowered to detect a difference.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4220993205">
         <span class="h4">
          Timing
         </span>
         <span class="headingEndMark">
          —
         </span>
         We initiate ATC within minutes to hours of ROSC. It is likely that the earlier TTM is started, the greater the potential benefit.
        </p>
        <p>
         In observational studies, delays in initiation of ATC were associated with worse neurologic outcomes in post-cardiac arrest survivors [
         <a href="#rid76">
          76-78
         </a>
         ]. However, there is no proven advantage to starting ATC while resuscitation is ongoing compared with early initiation following ROSC [
         <a href="#rid79">
          79
         </a>
         ]. In a trial in which patients were randomized to prehospital cooling initiated by paramedics or cooling started after hospital admission, prehospital cooling resulted in earlier achievement of target temperature, but mortality and neurologic outcomes were similar in both group [
         <a href="#rid80">
          80
         </a>
         ].
        </p>
        <p>
         Exceptions to early timing of ATC include the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients with resuscitated cardiac arrest who have evidence of ST segment elevation myocardial infarction (STEMI) on electrocardiogram (ECG). In such patients, urgent revascularization takes priority. ATC is generally initiated once revascularization has occurred, although it may also be initiated earlier if it does not result in delay of revascularization. (See
         <a class="medical medical_review" href="/z/d/html/66.html" rel="external">
          "Overview of the acute management of ST-elevation myocardial infarction", section on 'Choosing and initiating reperfusion with PCI or fibrinolysis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In patients who have documented intracranial hemorrhage, ATC should not delay neurology and neurosurgery evaluation. (See
         <a class="medical medical_review" href="/z/d/html/1084.html" rel="external">
          "Spontaneous intracerebral hemorrhage: Acute treatment and prognosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3081929067">
         <span class="h3">
          Maintenance
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Monitoring core temperature
         </strong>
         – We monitor core body temperature (which closely approximates brain temperature) continuously [
         <a href="#rid81">
          81
         </a>
         ]. Axillary and tympanic membrane measurements should not be used since they do not adequately measure core temperature.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Although the gold standard for core temperature measurement is the measurement of central venous temperature, other less invasive options are typically used. These include esophageal, bladder, and rectal temperature probes [
         <a href="#rid82">
          82
         </a>
         ]. Data suggest that esophageal temperature monitoring is the most accurate method to approximate core body temperature [
         <a href="#rid83">
          83
         </a>
         ]. Bladder monitoring may be inaccurate as urine output rates fluctuate post-arrest. Rectal measurements may also be inaccurate, as the rectal temperature may lag behind the core temperature [
         <a href="#rid82">
          82
         </a>
         ]. Selecting one of these three options is at the discretion of the institution and their policy regarding ATC. Importantly, the clinician should be aware of the accuracy of whatever modality they choose to use.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Sedation
         </strong>
         – We administer sedation during ATC. Common approaches to sedation in post-cardiac arrest patients include the following [
         <a href="#rid84">
          84
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Continuous infusions of
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         (20 mcg/kg/minute to a maximum dose of 50 mcg/kg/minute) and
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          fentanyl
         </a>
         (25 mcg/hour to 100 mcg/hour); alternatively, a propofol infusion with intermittent fentanyl boluses may be used if sufficient sedation and shivering suppression can be achieved with propofol alone.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         As an alternative to
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         in hypotensive patients, a continuous infusion of
         <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">
          midazolam
         </a>
         (2 to 10 mg/hour) can be considered. However, we prefer to avoid benzodiazepines, if feasible, since they may have a longer half-life and interfere with neurologic evaluation post-cooling.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Sedation should be titrated according to standard sedation scales and to suppress shivering. (See
         <a class="medical medical_review" href="/z/d/html/1606.html" rel="external">
          "Sedative-analgesia in ventilated adults: Management strategies, agent selection, monitoring, and withdrawal"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1616.html" rel="external">
          "Sedative-analgesia in ventilated adults: Medication properties, dose regimens, and adverse effects"
         </a>
         and
         <a class="local">
          'Adverse effects'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Monitoring for adverse effects
         </strong>
         – We monitor patients routinely during maintenance with hourly blood pressure measurement and continuous telemetry. We monitor for adverse effects including shivering, bleeding, arrhythmias, and electrolyte disturbances. The QT interval may be followed on telemetry and confirmed with an ECG when prolongation is suspected. (See
         <a class="local">
          'Adverse effects'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         We obtain the following laboratory tests every four hours:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Complete blood count with differential
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Chemistries including potassium, magnesium, and calcium levels
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Activated partial thromboplastin time and International Normalized Ratio (INR)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Lactic acid
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Cardiac enzymes (eg, troponin-I or -T)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1259565138">
         <span class="h3">
          Rewarming
         </span>
         <span class="headingEndMark">
          —
         </span>
         We suggest a slow rewarming phase, targeting a rise in temperature at a rate of 0.25 to 0.5°C per hour until normothermic. Slow rewarming avoids rapid fluxes in metabolic rates and plasma electrolyte concentrations, thereby avoiding hyperkalemia, seizures, and cerebral edema. In addition, we suggest the avoidance of fever during the rewarming phase and for 48 hours thereafter, to decrease the risk of deleterious neurologic effects related to hyperthermia [
         <a href="#rid37">
          37
         </a>
         ]. Our approach is consistent with guidelines from the European Resuscitation Council [
         <a href="#rid85">
          85
         </a>
         ].
        </p>
        <p>
         To control the rewarming process carefully, we advocate for the use of active automated devices rather than passive rewarming. Automated devices are often part of systems used for cooling and utilize surface or intravascular methods to slowly raise core body temperature back to normal [
         <a href="#rid86">
          86,87
         </a>
         ]. However, they may not be universally available. In such cases, the patient may be manually rewarmed by increasing the set point for the temperature by 0.5°C every two to three hours until a normal temperature is reached. For those receiving ATC at 36°C, passive rewarming by switching the device off is appropriate; however core temperature should still be measured for an additional 48 hours to ensure normothermia and avoidance of fever.
        </p>
        <p>
         If needed, the rate of rewarming can also be increased by raising the room temperature, applying a convective heating device, using heating lamps, or warming the inspired air via the ventilator heating circuit on the humidifier. These measures may be necessary when achieving the desired temperature increase per hour is not occurring with either active or passive rewarming techniques. While there are no data to determine the optimal timing for adding each of these rewarming interventions, it is reasonable to add them one at a time to avoid the adverse effects from overly rapid rewarming.
        </p>
        <p class="headingAnchor" id="H3097116739">
         <span class="h3">
          Duration
         </span>
         <span class="headingEndMark">
          —
         </span>
         The optimal duration of ATC is uncertain. For most patients managed with ATC following cardiac arrest, we suggest a duration of at least 24 hours, which is consistent with the 2015 American Heart Association guidelines [
         <a href="#rid37">
          37
         </a>
         ].
        </p>
        <p>
         In the available clinical trials of ATC, the duration of cooling ranged from 8 to 28 hours (see
         <a class="local">
          'Efficacy'
         </a>
         below). Whether extending ATC for longer than 24 hours is of additional benefit is not clear.
        </p>
        <p>
         The duration of fever prevention after the cooling period is also unclear. In one randomized trial of 789 patients who had been resuscitated after SCA, patients received ATC targeting 36°C for 24 hours followed by targeting of 37°C for either 12 hours (36 hours total ATC duration) or 48 hours (72 hours total ATC duration) [
         <a href="#rid88">
          88
         </a>
         ]. There was no difference in death or severe neurologic disability or coma at 90 days between the groups. However, the power of the study to detect a clinically meaningful difference of up to 27 percent improvement in the composite outcome (death or severe neurological injury) may have been limited since the power analysis occurred using data from another trial [
         <a href="#rid15">
          15,48
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1813287010">
         <span class="h2">
          Adverse effects
         </span>
         <span class="headingEndMark">
          —
         </span>
         The main adverse effects associated with TH are shivering and coagulopathy (and consequently bleeding). Others include arrhythmias, fluid and electrolyte imbalances, hyperglycemia, and an increased risk of infection.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Shivering
         </strong>
         – Shivering is a natural response to cooling that raises the core body temperature and interferes with achieving the target temperature [
         <a href="#rid89">
          89-92
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         We typically titrate patient sedation to suppress shivering (eg, increased rates of
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         and/or
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          fentanyl
         </a>
         infusions). In patients who are refractory to escalated sedation,
         <a class="drug drug_general" data-topicid="8897" href="/z/d/drug information/8897.html" rel="external">
          dexmedetomidine
         </a>
         , neuromuscular blocking agents (NMBAs), and
         <a class="drug drug_general" data-topicid="9608" href="/z/d/drug information/9608.html" rel="external">
          meperidine
         </a>
         are options. Dexmedetomidine can suppress shivering [
         <a href="#rid93">
          93
         </a>
         ], but has side effects of hypotension and bradycardia that may limit its use in patients with SCA. NMBAs are also effective but may mask seizure activity, and if used continuous EEG monitoring is prudent. Meperidine can also be used but has proconvulsant side effects and is not recommended in patients with renal failure, which is often present in patients with SCA.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Coagulopathy and bleeding
         </strong>
         – As the core body temperature decreases, platelet function diminishes and clotting enzymes are impaired [
         <a href="#rid94">
          94-98
         </a>
         ]. As a result, bleeding may be seen in up to 20 percent of patients being treated with ATC [
         <a href="#rid99">
          99
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In general, major bleeding that requires red blood cell transfusion is rare. If bleeding cannot be controlled (eg, noncompressible site, intracranial hemorrhage, etc), then ATC should be stopped and the patient should be rewarmed. Additional interventions for bleeding are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/1615.html" rel="external">
          "Use of blood products in the critically ill", section on 'Other approaches to treat or prevent bleeding'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Arrhythmias
         </strong>
         – Abnormal cardiac conduction and arrhythmias may be seen during TTM because cardiac electrical conduction is slowed by hypothermia, thereby precipitating arrhythmias [
         <a href="#rid100">
          100
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Bradycardia is the most common arrhythmia and acceptable heart rates as low as 40 beats per minute may be tolerated provided the blood pressure is appropriate.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Hypothermia-induced prolongation of the QT interval may also induce arrhythmias especially when the patient is receiving other medications that prolong the QT interval (eg, fluoroquinolones).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Depressed myocardial function can also occur during hypothermia, a phenomenon which should be kept in mind when assessing cardiac function following cardiac arrest.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Other non-ATC-related cardiovascular issues that arise in this population are discussed below. (See
         <a class="local">
          'Cardiovascular considerations'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Fluid and electrolyte imbalances
         </strong>
         – Hypothermia induces a "cold diuresis," which results in hypovolemia and electrolyte disturbances including hypokalemia, hypomagnesemia, and hypophosphatemia [
         <a href="#rid101">
          101
         </a>
         ]. When indicated, we administer fluid boluses (eg, 250 to 500 cc of crystalloid) and replace electrolytes.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hyperglycemia
         </strong>
         – Hyperglycemia due to insulin resistance has been noted during hypothermia and should be managed similar to that in any critically ill patient [
         <a href="#rid100">
          100,102
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1600.html" rel="external">
          "Glycemic control in critically ill adult and pediatric patients"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Increased risk of infection
         </strong>
         – The increased risk of infection related to ATC is thought to be due to impaired leukocyte function at lower temperatures [
         <a href="#rid51">
          51,103
         </a>
         ]. However, data from a large randomized trial that compared patients cooled to 33°C with patients maintained at 36°C, suggest no significant difference in infection rates between the groups [
         <a href="#rid68">
          68
         </a>
         ]. In addition, the increased risk of infection does not appear to be associated with an increase in mortality.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3172125800">
         <span class="h2">
          Efficacy
         </span>
         <span class="headingEndMark">
          —
         </span>
         The efficacy of ATC in patients with SCA is supported by randomized trials, meta-analyses, and observational studies demonstrating lower mortality and better neurologic outcomes in patients managed with TTM compared with those managed without ATC [
         <a href="#rid51">
          51,67-70,103-107
         </a>
         ]. Most patients enrolled in randomized trials evaluating ATC that demonstrated benefit had shockable rhythms (ie, VF and pulseless VT). The evidence supporting ATC in patients with nonshockable rhythms (eg, pulseless electrical activity [PEA] or asystole) is largely observational and remains conflicting.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Studies comparing ATC versus no ATC
         </strong>
         – In a meta-analysis of three trials in which 366 survivors of cardiac arrest (VF or VT in 87 percent) were randomized to ATC or standard care without ATC, patients in the ATC group had lower mortality (43 versus 56 percent; RR 0.79, 95% CI 0.66-0.95) and were more likely to have good neurologic outcome at hospital discharge (48 versus 39 percent; RR 1.41, 95% CI 1.09-1.82) [
         <a href="#rid69">
          69
         </a>
         ]. Similar findings were noted in another meta-analysis that included the same three trials plus eight observational studies [
         <a href="#rid107">
          107
         </a>
         ]. A meta-analysis of 12 trials totaling 3956 patients found that patients treated with TH were more likely to have favorable neurological outcome (RR 1.60, 95% CI 1.15 to 2.23; low certainty of the evidence) [
         <a href="#rid108">
          108
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Studies comparing TH versus normothermia
         </strong>
         – These data are discussed above. (See
         <a class="local">
          'Setting the target temperature'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Impact of cardiac rhythm
         </strong>
         – Evidence in support of ATC is more robust in patients with VF and pulseless VT than those with nonshockable rhythms (eg, PEA or asystole):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          VF and pulseless VT
         </strong>
         – The randomized trials and meta-analyses discussed in the previous sections have demonstrated that ATC reduces mortality and improves neurologic outcomes in patients who have out-of-hospital cardiac arrest with an initial rhythm of VF or pulseless VT [
         <a href="#rid51">
          51,67
         </a>
         ]. The benefit is assumed to extend to patients with in-hospital cardiac arrest from VF and pulseless VT.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Nonshockable rhythms
         </strong>
         – The evidence supporting ATC in patients with SCA who have initial rhythms other than VF or pulseless VT is less robust than that in patients with shockable rhythms [
         <a href="#rid109">
          109-122
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         In one small randomized trial, 30 patients with PEA or asystole were randomized to TH (target temperature 34°C) or normothermia [
         <a href="#rid121">
          121
         </a>
         ]. The study did not detect a difference in mortality, which was similarly high in both groups (81 and 93 percent); however, the trial was not adequately powered to detect a true difference.
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Similarly, in another randomized trial of 584 patients, mortality was no different among patients who underwent TH (target temperature 33°C) compared with those in whom normothermia was targeted, although there was a higher percentage of patients with improved neurologic outcomes in the TH group [
         <a href="#rid122">
          122
         </a>
         ]. In contrast, a post-hoc analysis of this trial reported that TH was associated with better neurologic outcomes on day 90 in patients with a nonshockable rhythm compared with normothermic patients [
         <a href="#rid123">
          123
         </a>
         ]. However, the sample size was limited, resulting in wide confidence intervals, thereby limiting the interpretation of this finding.
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Observational data are conflicting, with some studies suggesting lower mortality in patients with nonshockable cardiac arrest who received ATC compared with those who did not receive ATC [
         <a href="#rid109">
          109-112,120
         </a>
         ]. In contrast, other studies have not found significant improvement in survival or neurologic outcome in this population [
         <a href="#rid113">
          113-119
         </a>
         ]. A systematic review of 10 nonrandomized studies of patients with cardiac arrest due to nonshockable rhythms demonstrated a lower in-hospital mortality in patients treated with ATC (RR 0.86, 95% CI 0.76-0.99), and a nonsignificant trend towards lower risk of poor neurologic outcome at discharge (RR 0.96, 95% CI 0.90-1.02); however, the quality of evidence was low [
         <a href="#rid120">
          120
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H433480956">
         <span class="h1">
          NEUROLOGIC CONSIDERATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hypoxic encephalopathy, cerebral edema, seizure activity, and myoclonic jerks, are common after sudden cardiac arrest (SCA) and often indicate severe brain injury. We perform daily examination that also includes assessment of brainstem function. In addition, we typically obtain electroencephalography (EEG) and CT of the brain to assist in this evaluation, since collectively these data can support clinical findings and inform prognosis [
         <a href="#rid124">
          124
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2014097726">
         <span class="h2">
          Hypoxic brain injury and cerebral edema
         </span>
         <span class="headingEndMark">
          —
         </span>
         The most common cause of death and morbidity in patients after resuscitated cardiac arrest is hypoxic encephalopathy [
         <a href="#rid125">
          125
         </a>
         ]. Further details regarding the evaluation of patients with hypoxic brain injury are provided separately. (See
         <a class="medical medical_review" href="/z/d/html/4833.html" rel="external">
          "Hypoxic-ischemic brain injury in adults: Evaluation and prognosis"
         </a>
         .)
        </p>
        <p>
         Active temperature control (ATC) is focused on reducing death and improving neurologic recovery from hypoxic brain injury. ATC is discussed separately. (See
         <a class="local">
          'Active temperature control'
         </a>
         above.)
        </p>
        <p>
         Positioning patients with the head of the bed at 30 degrees is typical in mechanically ventilated patients and helps lower the intracranial pressure by improving outflow from the brain.
        </p>
        <p class="headingAnchor" id="H1658882889">
         <span class="h2">
          Seizures
         </span>
         <span class="headingEndMark">
          —
         </span>
         In patients who are treated with ATC post-cardiac arrest, the incidence of seizures may be as high as 33 percent [
         <a href="#rid126">
          126
         </a>
         ]. Many seizures in patients with hypoxic encephalopathy from SCA are nonconvulsive, clinically subtle, and often require EEG for detection  (
         <a class="graphic graphic_table graphicRef88652" href="/z/d/graphic/88652.html" rel="external">
          table 4
         </a>
         ). A smaller proportion are convulsive.
        </p>
        <p class="headingAnchor" id="H1878205664">
         <span class="h3">
          Electroencephalography
         </span>
         <span class="headingEndMark">
          —
         </span>
         Whether continuous EEG monitoring should be routinely performed following cardiac arrest is unclear, in part because of uncertainty as to whether aggressive treatment of nonconvulsive or convulsive epileptiform activity improves neurologic outcomes [
         <a href="#rid127">
          127,128
         </a>
         ]. Nonetheless, in patients with SCA undergoing ATC (ie, comatose patients), we perform continuous EEG monitoring in order to detect subclinical seizure activity. We advocate that continuous EEG monitoring begin as early as feasible, generally within 6 to 12 hours of ATC initiation. We continue EEG monitoring through the ATC period and for at least 24 hours after rewarming.
        </p>
        <p>
         However, continuous EEG monitoring is not universally available. In such circumstances, a strategy of intermittent EEG monitoring may be utilized in the 6 to 12 hour range after ATC initiation and then again at least 24 hours after rewarming. One small prospective study suggested that standard intermittent EEG had comparable performance with continuous EEG monitoring for evaluation, although data were flawed [
         <a href="#rid129">
          129
         </a>
         ].
        </p>
        <p>
         Interpretation of EEG patterns in comatose patients after hypoxic brain injury may be difficult due to the effect of sedation. In addition, muscle movements occurring during the rewarming phase of ATC may cause artifact that can complicate interpretation. We prefer direct discussion with a consulting neurologist or epileptologist to integrate clinical and EEG data in order to facilitate management of EEG findings. (See
         <a class="medical medical_review" href="/z/d/html/14103.html" rel="external">
          "Nonconvulsive status epilepticus: Classification, clinical features, and diagnosis", section on 'Electroencephalography'
         </a>
         .)
        </p>
        <p>
         In patients with SCA, EEG patterns that are generally associated with a poor prognosis and reduced hospital survival (0 to 12 percent) are termed "malignant" EEG patterns. These include [
         <a href="#rid130">
          130-133
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Nonconvulsive status epilepticus
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Convulsive status epilepticus
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Myoclonic status epilepticus
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Rhythmic and periodic epileptiform discharges
        </p>
        <p>
        </p>
        <p>
         Malignant epileptiform patterns are less common in patients with early, diffuse cerebral edema; these patients tend to have suppression burst or complete suppression as their primary EEG pattern, and also have a poor prognosis [
         <a href="#rid134">
          134
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2233.html" rel="external">
          "Electroencephalography (EEG) in the diagnosis of seizures and epilepsy"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3020265411">
         <span class="h3">
          Treatment
         </span>
         <span class="headingEndMark">
          —
         </span>
         In patients with SCA who have epileptiform discharges that progress to outright seizures (either convulsive or nonconvulsive), we treat with anti-epileptiform agents. While the identification of those with convulsive seizures may be obvious, identifying an outright seizure in those with suspected nonconvulsive seizures may be more challenging. Identifying intermittent eye blinking, nystagmus, or facial twitching can often be clues to progression to seizure, and these should trigger consultation with a neurologist or epileptologist.
        </p>
        <p>
         Among the options, there is no single agent that is superior. Thus, we prefer a therapeutic approach similar to that described in patients with seizures due to non-SCA etiologies  (
         <a class="graphic graphic_table graphicRef94778" href="/z/d/graphic/94778.html" rel="external">
          table 5
         </a>
         and
         <a class="graphic graphic_algorithm graphicRef74649" href="/z/d/graphic/74649.html" rel="external">
          algorithm 1
         </a>
         ). This includes benzodiazepines for acute seizure treatment followed by a preventative agent, such as
         <a class="drug drug_general" data-topicid="10035" href="/z/d/drug information/10035.html" rel="external">
          valproic acid
         </a>
         ,
         <a class="drug drug_general" data-topicid="9904" href="/z/d/drug information/9904.html" rel="external">
          levetiracetam
         </a>
         ,
         <a class="drug drug_general" data-topicid="10268" href="/z/d/drug information/10268.html" rel="external">
          lacosamide
         </a>
         , or
         <a class="drug drug_general" data-topicid="9769" href="/z/d/drug information/9769.html" rel="external">
          phenytoin
         </a>
         (may be associated with hypotension). However, treatment of seizures in this setting is challenging because many are refractory to single agent therapy. For refractory cases, double or triple agent oral therapy as well as
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         or
         <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">
          midazolam
         </a>
         infusions, or
         <a class="drug drug_general" data-topicid="9763" href="/z/d/drug information/9763.html" rel="external">
          phenobarbital
         </a>
         may be appropriate. (See
         <a class="medical medical_review" href="/z/d/html/129547.html" rel="external">
          "Nonconvulsive status epilepticus: Treatment and prognosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/96933.html" rel="external">
          "Convulsive status epilepticus in adults: Management", section on 'Emergency antiseizure treatment'
         </a>
         .)
        </p>
        <p>
         Data to support the optimal approach in this population are limited to single center case series. As an example, in one series, anticonvulsive treatment improved EEG status epilepticus patterns temporarily (ie, &lt;6 hours) [
         <a href="#rid135">
          135
         </a>
         ]. However, there was no difference in neurologic recovery between patients treated with or without anti-epileptic agents and neurologic outcomes in general were poor.
        </p>
        <p class="headingAnchor" id="H833497020">
         <span class="h3">
          Prophylaxis
         </span>
         <span class="headingEndMark">
          —
         </span>
         We do not routinely administer seizure prophylaxis since there is no high-quality evidence that clearly demonstrates benefit from seizure prophylaxis in the post-cardiac arrest patient.
        </p>
        <p>
         In support of this practice, one open-label trial of 172 survivors of cardiac arrest who had rhythmic and periodic EEG patterns compared prophylactic antiseizure medication for at least 48 hours plus standard care with standard care alone [
         <a href="#rid136">
          136
         </a>
         ]. Despite effective suppression of EEG activity in 56 percent of patients in the antiseizure medication group, there was no difference between the groups in the rate of poor neurologic outcome (90 versus 92 percent) or mortality (80 versus 82 percent).
        </p>
        <p class="headingAnchor" id="H2664507309">
         <span class="h2">
          Myoclonic jerks
         </span>
         <span class="headingEndMark">
          —
         </span>
         Myoclonic jerks and other movements are common after cardiac arrest. Myoclonus can be epileptic (ie, driven by an epileptic focus in the brain) or nonepileptic (also known as "isolated" myoclonus). EEG is used to distinguish these from one another. Consultation with a neurologist is critical to interpret EEG patterns associated with myoclonus. The classification and evaluation of myoclonus is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/4885.html" rel="external">
          "Classification and evaluation of myoclonus"
         </a>
         .)
        </p>
        <p>
         Our treatment strategies are similar to those in non-SCA-related myoclonus. In general, for patients with mild or intermittent nonepileptiform myoclonus, we either treat with an intermittent benzodiazepine (eg,
         <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">
          midazolam
         </a>
         or
         <a class="drug drug_general" data-topicid="9284" href="/z/d/drug information/9284.html" rel="external">
          clonazepam
         </a>
         ) or elect not to treat it. For patients who have severe myoclonus (eg, myoclonus causing dyssynchrony or rhabdomyolysis, myoclonus that prevents adequate care or reduces safety for interventions) or epileptiform myoclonus, we prefer treatment using scheduled
         <a class="drug drug_general" data-topicid="9904" href="/z/d/drug information/9904.html" rel="external">
          levetiracetam
         </a>
         with or without scheduled midazolam or clonazepam and/or a
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         infusion. Additional details regarding treatment of myoclonus is provided separately. (See
         <a class="medical medical_review" href="/z/d/html/4888.html" rel="external">
          "Treatment of myoclonus"
         </a>
         .)
        </p>
        <p>
         Nonepileptic myoclonic jerks in patients following cardiac arrest are generally benign and do not have prognostic significance. Conversely, status myoclonus, defined as repetitive myoclonic jerks lasting more than 30 minutes, is generally a poor prognostic sign. For example, in one study of 401 patients with myoclonus following SCA, three quarters were found to have early postanoxic multifocal myoclonus (PAMM) that was associated with suppression-burst background and high-amplitude polyspikes [
         <a href="#rid137">
          137
         </a>
         ]; no patients with this pattern survived. Anti-seizure medication may not improve the outcome [
         <a href="#rid138">
          138
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H137772097">
         <span class="h1">
          CARDIOVASCULAR CONSIDERATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most patients with sudden cardiac arrest (SCA) are managed collaboratively by intensivists and cardiologists. The cardiologist assessment is important for evaluation and management of cardiac ischemia and other potential cardiac etiologies associated with SCA. Discussion in this section is limited to ICU-specific measures while a detailed approach to cardiac evaluation of the survivor of SCA is provided separately. (See
         <a class="medical medical_review" href="/z/d/html/970.html" rel="external">
          "Cardiac evaluation of the survivor of sudden cardiac arrest"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1804812788">
         <span class="h2">
          Electrocardiography and echocardiography
         </span>
         <span class="headingEndMark">
          —
         </span>
         We typically follow patients for three days with daily electrocardiography (ECG) and additional ECGs as needed for suspected ischemic or arrhythmic events.
        </p>
        <p>
         Follow-up echocardiography may also be performed, generally 48 hours or more after cardiac arrest to assess myocardial and valvular function. Low ejection fractions noted during or immediately following arrest often improve by this time and lack of resolution may suggest an underlying pathology. A significant proportion of patients with SCA have myocardial dysfunction, ranging from 33 to 44 percent [
         <a href="#rid139">
          139,140
         </a>
         ]. In one study, myocardial dysfunction was associated with male sex, a history of congestive heart failure, longer duration of resuscitation, and therapeutic hypothermia [
         <a href="#rid140">
          140
         </a>
         ]. Further details regarding echocardiography in the evaluation of patients with SCA are provided separately. (See
         <a class="medical medical_review" href="/z/d/html/970.html" rel="external">
          "Cardiac evaluation of the survivor of sudden cardiac arrest", section on 'Echocardiography'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3629724190">
         <span class="h2">
          Ongoing assessment of the need for revascularization
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients who did not have revascularization performed immediately following cardiac arrest, a low threshold should be maintained for performing coronary angiography in those at risk. The value of diagnostic angiography in patients with SCA is discussed separately. (See
         <a class="local">
          'Assessing the need for immediate coronary revascularization'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/970.html" rel="external">
          "Cardiac evaluation of the survivor of sudden cardiac arrest", section on 'Coronary angiography'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/970.html" rel="external">
          "Cardiac evaluation of the survivor of sudden cardiac arrest"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H183790346">
         <span class="h2">
          Management of persistent cardiogenic shock
         </span>
         <span class="headingEndMark">
          —
         </span>
         In some patients, cardiogenic shock follows successfully resuscitated cardiac arrest. It is managed similar to cardiogenic shock due to other etiologies and in some cases needs extracorporeal membrane oxygenation. (See
         <a class="medical medical_review" href="/z/d/html/83.html" rel="external">
          "Prognosis and treatment of cardiogenic shock complicating acute myocardial infarction"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/134279.html" rel="external">
          "Extracorporeal life support in adults: Management of venoarterial extracorporeal membrane oxygenation (V-A ECMO)", section on 'Refractory cardiogenic shock'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4255532543">
         <span class="h1">
          OTHER COMPLICATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Following sudden cardiac arrest patients may suffer from ischemic injury to other vital organs, the management of which is largely supportive (eg, acute kidney injury, shock liver, ischemic bowel). (See
         <a class="medical medical_review" href="/z/d/html/14035.html" rel="external">
          "Overview of the management of acute kidney injury (AKI) in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3593.html" rel="external">
          "Ischemic hepatitis, hepatic infarction, and ischemic cholangiopathy"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/91221.html" rel="external">
          "Nonocclusive mesenteric ischemia"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2763249804">
         <span class="h1">
          SPECIAL POPULATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Details regarding management of special populations are found in the following links:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1922.html" rel="external">
          "Evaluation of sudden cardiac arrest and sudden cardiac death in patients on dialysis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/14184.html" rel="external">
          "Sudden cardiac arrest and death in pregnancy", section on 'Postarrest care'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/93789.html" rel="external">
          "Anesthesia for emergency surgery after cardiac arrest"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3593028048">
         <span class="h1">
          PROGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The overall prognosis of patients following cardiac arrest remains poor, with approximately 50 percent of patients surviving to discharge [
         <a href="#rid68">
          68,141
         </a>
         ]. Prognosis is determined mostly by the extent of hypoxic brain injury but also by several other factors including the reversibility of the underlying etiology for sudden cardia arrest (SCA), comorbidities, and complications associated with critical illness (eg, acute respiratory distress syndrome, acute kidney injury).
         <strong>
         </strong>
         Poor prognostic factors are listed in the table  (
         <a class="graphic graphic_table graphicRef69852" href="/z/d/graphic/69852.html" rel="external">
          table 6
         </a>
         ).
        </p>
        <p>
         Early prognostication in patients with SCA can be difficult. Serial neurologic assessment together with electroencephalographic data and CT of the brain are key components that help determine the overall neurologic prognosis [
         <a href="#rid124">
          124
         </a>
         ]. Generally, the earliest time interval for neurologic prognostication should be at least 72 hours after rewarming [
         <a href="#rid37">
          37
         </a>
         ]. This time point allows for sedative and/or paralytic medications to be cleared from the system, but longer periods of time may be necessary.
        </p>
        <p>
         Post-cardiac arrest scores have been developed, but generally these include cardiac arrest-specific data that are not always reliably recorded [
         <a href="#rid142">
          142-144
         </a>
         ].
        </p>
        <p>
         Further details regarding the prognosis of patients with SCA and prognosis of patients with hypoxic brain injury are provided separately. (See
         <a class="medical medical_review" href="/z/d/html/973.html" rel="external">
          "Prognosis and outcomes following sudden cardiac arrest in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4833.html" rel="external">
          "Hypoxic-ischemic brain injury in adults: Evaluation and prognosis"
         </a>
         .)
        </p>
        <p>
         We set realistic expectations with families and loved-ones early during the course in the ICU. We pursue active and engaged interaction with families in the hours and days post-arrest to help determine the patient's wishes. (See
         <a class="medical medical_review" href="/z/d/html/1643.html" rel="external">
          "Communication in the ICU: Holding a meeting with families and caregivers"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/83235.html" rel="external">
          "Palliative care: Issues in the intensive care unit in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/16295.html" rel="external">
          "Withholding and withdrawing ventilatory support in adults in the intensive care unit"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/16296.html" rel="external">
          "Ethics in the intensive care unit: Responding to requests for potentially inappropriate therapies in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2477484177">
         <span class="h1">
          REFERRAL TO SPECIALIZED CENTER FOR POSTRESUSCITATION CARE
         </span>
         <span class="headingEndMark">
          —
         </span>
         The American Heart Association has proposed that following successful resuscitation for cardiac arrest, patients may benefit from referral to regionalized centers for post-cardiac arrest care [
         <a href="#rid108">
          108
         </a>
         ]. However, this is not yet routine. Further discussion on this matter is provided separately. (See
         <a class="medical medical_review" href="/z/d/html/13838.html" rel="external">
          "Initial assessment and management of the adult post-cardiac arrest patient", section on 'Patient disposition'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3817285569">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/117075.html" rel="external">
          "Society guideline links: Basic and advanced cardiac life support in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3657624670">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topic (see
         <a class="medical medical_basics" href="/z/d/html/82912.html" rel="external">
          "Patient education: Sudden cardiac arrest (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1302503990">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Assessment
         </strong>
         – For patients who arrive to the intensive care unit (ICU) with return of spontaneous circulation (ROSC) following sudden cardiac arrest (SCA), initial assessment is focused on assessing the etiology and complications of SCA  (
         <a class="graphic graphic_table graphicRef70060" href="/z/d/graphic/70060.html" rel="external">
          table 1
         </a>
         and
         <a class="graphic graphic_table graphicRef52416" href="/z/d/graphic/52416.html" rel="external">
          table 2
         </a>
         ). We encourage a multidisciplinary approach to management.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         We review records of the event, obtain an expanded history from close contacts and witnesses, and perform a brief physical, neurologic, hemodynamic, and device assessment (eg, pacemaker, venous access). Repeat testing includes electrocardiogram (ECG), a chest radiograph, complete blood count, troponin I or T, brain natriuretic peptide, (BNP; or N-terminal BNP), chemistries, coagulation studies, liver function tests, and arterial blood gases. (See
         <a class="local">
          'Immediate post-cardiac arrest assessment and testing'
         </a>
         above and
         <a class="local">
          'Reassessment of cardiac arrest etiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         We also typically assess (or reassess) the need for coronary revascularization (immediate or delayed) as well as the need for other interventions (eg, pericardial drain, permanent pacemaker, and central venous and arterial access). (See
         <a class="local">
          'Assessing the need for immediate coronary revascularization'
         </a>
         above and
         <a class="local">
          'Assess need for other immediate interventions'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          General critical care management
         </strong>
         – General critical care management is aimed at ensuring continued hemodynamic stability. This includes the following (see
         <a class="local">
          'General critical care management'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Mechanical ventilation
         </strong>
         – Most patients who survive SCA are intubated and mechanically ventilated. We suggest targeting normal CO
         <sub>
          2
         </sub>
         and oxygen levels rather than other strategies (eg, permissive hypercapnia) during the initial post-arrest period (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). Typical targets are arterial CO
         <sub>
          2
         </sub>
         tension (PaCO
         <sub>
          2
         </sub>
         ) 35 to 45 mmHg, peripheral oxygen saturation (SpO
         <sub>
          2
         </sub>
         ) between 94 and 96 percent, and arterial oxygen tension (PaO
         <sub>
          2
         </sub>
         ) between 65 and 100 mmHg, understanding that therapeutic hypothermia may falsely lower the PaCO
         <sub>
          2
         </sub>
         and raise the PaO
         <sub>
          2
         </sub>
         . (See
         <a class="local">
          'Airway, ventilation, and oxygen targets'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Hemodynamic support
         </strong>
         – Fluid therapy and vasopressor support should be adjusted to maintain euvolemia and adequate perfusion during the post-arrest period. Typical targets are a systolic blood pressure of 90 mmHg and mean arterial pressure of 65 mmHg. For most patients who require vasopressor therapy, we suggest
         <a class="drug drug_general" data-topicid="9709" href="/z/d/drug information/9709.html" rel="external">
          norepinephrine
         </a>
         as the first-line vasopressor (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). (See
         <a class="local">
          'Hemodynamic monitoring and goals'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Bundled care
         </strong>
         – Patients should receive bundled care including (see
         <a class="local">
          'General supportive care'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Ventilator-associated pneumonia prevention measures. We suggest careful vigilance and monitoring and reserving antibiotics for patients with clinical concern for pneumonia rather than administering prophylactic antibiotics for the prevention of pneumonia (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). (See
         <a class="local">
          'Antibiotic therapy and prophylaxis'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/6995.html" rel="external">
          "Risk factors and prevention of hospital-acquired and ventilator-associated pneumonia in adults", section on 'Prevention'
         </a>
         .)
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Stress ulcer prophylaxis. (See
         <a class="medical medical_review" href="/z/d/html/1611.html" rel="external">
          "Stress ulcers in the intensive care unit: Diagnosis, management, and prevention"
         </a>
         .)
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Venous thromboembolism prophylaxis. (See
         <a class="medical medical_review" href="/z/d/html/1346.html" rel="external">
          "Prevention of venous thromboembolic disease in acutely ill hospitalized medical adults"
         </a>
         .)
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Physical therapy. (See
         <a class="medical medical_review" href="/z/d/html/88330.html" rel="external">
          "Post-intensive care syndrome (PICS) in adults: Clinical features and diagnostic evaluation"
         </a>
         .)
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Nutrition. (See
         <a class="medical medical_review" href="/z/d/html/1617.html" rel="external">
          "Nutrition support in intubated critically ill adult patients: Initial evaluation and prescription"
         </a>
         .)
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Glycemic control measures. (See
         <a class="medical medical_review" href="/z/d/html/1600.html" rel="external">
          "Glycemic control in critically ill adult and pediatric patients"
         </a>
         .)
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Transfusions if indicated. (See
         <a class="medical medical_review" href="/z/d/html/1615.html" rel="external">
          "Use of blood products in the critically ill", section on 'RBC indications'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         It is important to discuss the patient's wishes with the family/health care proxy and establish goals of care early. (See
         <a class="local">
          'Antibiotic therapy and prophylaxis'
         </a>
         above and
         <a class="local">
          'Early discussion of the patient's wishes'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Active temperature control
         </strong>
         – The purpose of active temperature control (ATC) is the avoidance of harm associated with fever based upon data that suggest a mortality and neurologic benefit.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Indications
         </strong>
         – For patients who achieve ROSC following arrest due to ventricular fibrillation and pulseless ventricular tachycardia but do
         <strong>
          not
         </strong>
         initially have purposeful neurologic activity on examination, we recommend ATC rather than no ATC (
         <a class="grade" href="https:///uptodate/show/grade_2" rel="external">
          Grade 1B
         </a>
         ). In randomized trials in this population, ATC reduced mortality and improved neurologic outcomes. For patients with ROSC following nonshockable rhythms (eg, pulseless electrical activity and asystole), we suggest ATC (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). The efficacy of ATC in this setting is less certain, but observational data suggest a possible benefit. (See
         <a class="local">
          'Active temperature control'
         </a>
         above and
         <a class="local">
          'Efficacy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Setting the target temperature
         </strong>
         – We suggest a target temperature between 33 and 37.5°C rather than higher or lower targets (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). Patient-specific factors may influence whether the lower or upper end of the target range is selected. For example, targeted normothermia (eg, 36.4 to 37.5°C) may be preferred in patients with mild brain injury or higher bleeding risk, while targeted hypothermia (eg, 33 to 36°C) may be preferred in those who are not actively bleeding or those with severe brain injury, stroke, subarachnoid hemorrhage, or hepatic encephalopathy. The target temperature typically is maintained using an automated cooling device with a feedback mechanism to achieve rapid cooling. (See
         <a class="local">
          'Initiation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Timing
         </strong>
         – Following ROSC, we typically start ATC as soon as is feasible (ie, within minutes to hours; the earlier the better) but should not delay coronary angiography if needed in the setting of ST segment elevation myocardial infarction. We suggest that ATC be continued for 24 to 48 hours rather than shorter or longer hours (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ) and be followed by gradual rewarming (0.25 to 0.5°C per hour). Fever should be avoided for an additional 48 hours after ATC is discontinued (See
         <a class="local">
          'Maintenance'
         </a>
         above and
         <a class="local">
          'Rewarming'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Adverse effects
         </strong>
         – Adverse effects including shivering, bleeding from coagulopathy, arrhythmias, fluid and electrolyte imbalances, and hyperglycemia are managed supportively. (See
         <a class="local">
          'Adverse effects'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Neurologic considerations
         </strong>
         – In patients with SCA, hypoxic encephalopathy, cerebral edema, seizure activity, and myoclonic jerks are common and often indicate severe brain injury and a poor prognosis.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         We perform daily examination that also includes assessment of brainstem function. In addition, we typically obtain electroencephalography (EEG) and CT of the brain to assist in this evaluation; collectively, these data can support clinical findings and inform prognosis. Seizures are typically nonconvulsive, clinically subtle, and often require continuous EEG for detection  (
         <a class="graphic graphic_table graphicRef88652" href="/z/d/graphic/88652.html" rel="external">
          table 4
         </a>
         ). (See
         <a class="local">
          'Neurologic considerations'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Treatment of hypoxic brain injury and cerebral edema are largely supportive. (See
         <a class="medical medical_review" href="/z/d/html/4833.html" rel="external">
          "Hypoxic-ischemic brain injury in adults: Evaluation and prognosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1659.html" rel="external">
          "Evaluation and management of elevated intracranial pressure in adults", section on 'General management'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Patients with SCA who have clinically apparent seizures require anticonvulsant therapy  (
         <a class="graphic graphic_table graphicRef94778" href="/z/d/graphic/94778.html" rel="external">
          table 5
         </a>
         and
         <a class="graphic graphic_algorithm graphicRef74649" href="/z/d/graphic/74649.html" rel="external">
          algorithm 1
         </a>
         ). Patients are often refractory and need combination therapy to control seizure activity. (See
         <a class="local">
          'Seizures'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/129547.html" rel="external">
          "Nonconvulsive status epilepticus: Treatment and prognosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/96933.html" rel="external">
          "Convulsive status epilepticus in adults: Management", section on 'Emergency antiseizure treatment'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For patients with myoclonus following SCA, treatment strategies are similar to those in non-SCA-related myoclonus (eg, benzodiazepine for non-epileptiform myoclonus or
         <a class="drug drug_general" data-topicid="9904" href="/z/d/drug information/9904.html" rel="external">
          levetiracetam
         </a>
         for epileptiform myoclonus). (See
         <a class="local">
          'Myoclonic jerks'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/4888.html" rel="external">
          "Treatment of myoclonus"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cardiovascular considerations
         </strong>
         – A cardiologist assessment is important for evaluation and management of cardiac ischemia and other potential cardiac etiologies associated with SCA.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         ECGs may be followed serially for three days or as needed for suspected ischemic or arrhythmic events. Follow-up echocardiography may also be performed, generally 48 or more hours after cardiac arrest to assess myocardial and valvular function. (See
         <a class="local">
          'Cardiovascular considerations'
         </a>
         above and
         <a class="local">
          'Electrocardiography and echocardiography'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         A low threshold should be maintained for performing coronary angiography in those at risk (eg, patients with known pre-existing coronary artery disease, evidence of recurrent ischemia, electrical or hemodynamic instability, or witnessed chest pain prior to SCA). (See
         <a class="local">
          'Cardiovascular considerations'
         </a>
         above and
         <a class="local">
          'Assessing the need for immediate coronary revascularization'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/970.html" rel="external">
          "Cardiac evaluation of the survivor of sudden cardiac arrest"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/970.html" rel="external">
          "Cardiac evaluation of the survivor of sudden cardiac arrest", section on 'Echocardiography'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Prognosis
         </strong>
         – In patients with SCA, prognosis is generally poor. Prognosis is determined mostly by the extent of hypoxic brain injury but also by several other factors including the reversibility of the underlying etiology for SCA, comorbidities, and complications associated with critical illness (eg, acute respiratory distress syndrome, acute kidney injury). Poor prognostic factors are listed in the table  (
         <a class="graphic graphic_table graphicRef69852" href="/z/d/graphic/69852.html" rel="external">
          table 6
         </a>
         ). (See
         <a class="local">
          'Prognosis'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Virani SS, Alonso A, Benjamin EJ, et al. Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association. Circulation 2020; 141:e139.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nolan JP, Sandroni C, Böttiger BW, et al. European Resuscitation Council and European Society of Intensive Care Medicine guidelines 2021: post-resuscitation care. Intensive Care Med 2021; 47:369.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sandroni C, Nolan JP, Andersen LW, et al. ERC-ESICM guidelines on temperature control after cardiac arrest in adults. Intensive Care Med 2022; 48:261.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Drory Y, Turetz Y, Hiss Y, et al. Sudden unexpected death in persons less than 40 years of age. Am J Cardiol 1991; 68:1388.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kuisma M, Alaspää A. Out-of-hospital cardiac arrests of non-cardiac origin. Epidemiology and outcome. Eur Heart J 1997; 18:1122.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hwang S, Shin SD, Lee K, et al. Cardiac arrest in schools: Nationwide incidence, risk, and outcome. Resuscitation 2017; 110:81.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hess EP, Campbell RL, White RD. Epidemiology, trends, and outcome of out-of-hospital cardiac arrest of non-cardiac origin. Resuscitation 2007; 72:200.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Branch KRH, Strote J, Gunn M, et al. Early head-to-pelvis computed tomography in out-of-hospital circulatory arrest without obvious etiology. Acad Emerg Med 2021; 28:394.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Karatasakis A, Sarikaya B, Liu L, et al. Prevalence and Patterns of Resuscitation-Associated Injury Detected by Head-to-Pelvis Computed Tomography After Successful Out-of-Hospital Cardiac Arrest Resuscitation. J Am Heart Assoc 2022; 11:e023949.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Trzeciak S, Jones AE, Kilgannon JH, et al. Significance of arterial hypotension after resuscitation from cardiac arrest. Crit Care Med 2009; 37:2895.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bray JE, Bernard S, Cantwell K, et al. The association between systolic blood pressure on arrival at hospital and outcome in adults surviving from out-of-hospital cardiac arrests of presumed cardiac aetiology. Resuscitation 2014; 85:509.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kilgannon JH, Roberts BW, Reihl LR, et al. Early arterial hypotension is common in the post-cardiac arrest syndrome and associated with increased in-hospital mortality. Resuscitation 2008; 79:410.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gaieski DF, Band RA, Abella BS, et al. Early goal-directed hemodynamic optimization combined with therapeutic hypothermia in comatose survivors of out-of-hospital cardiac arrest. Resuscitation 2009; 80:418.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sunde K, Pytte M, Jacobsen D, et al. Implementation of a standardised treatment protocol for post resuscitation care after out-of-hospital cardiac arrest. Resuscitation 2007; 73:29.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kjaergaard J, Møller JE, Schmidt H, et al. Blood-Pressure Targets in Comatose Survivors of Cardiac Arrest. N Engl J Med 2022; 387:1456.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           De Backer D, Biston P, Devriendt J, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010; 362:779.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rui Q, Jiang Y, Chen M, et al. Dopamine versus norepinephrine in the treatment of cardiogenic shock: A PRISMA-compliant meta-analysis. Medicine (Baltimore) 2017; 96:e8402.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reynolds JC, Callaway CW, El Khoudary SR, et al. Coronary angiography predicts improved outcome following cardiac arrest: propensity-adjusted analysis. J Intensive Care Med 2009; 24:179.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Redfors B, Råmunddal T, Angerås O, et al. Angiographic findings and survival in patients undergoing coronary angiography due to sudden cardiac arrest in western Sweden. Resuscitation 2015; 90:13.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Millin MG, Comer AC, Nable JV, et al. Patients without ST elevation after return of spontaneous circulation may benefit from emergent percutaneous intervention: A systematic review and meta-analysis. Resuscitation 2016; 108:54.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dumas F, Cariou A, Manzo-Silberman S, et al. Immediate percutaneous coronary intervention is associated with better survival after out-of-hospital cardiac arrest: insights from the PROCAT (Parisian Region Out of hospital Cardiac ArresT) registry. Circ Cardiovasc Interv 2010; 3:200.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Camuglia AC, Randhawa VK, Lavi S, Walters DL. Cardiac catheterization is associated with superior outcomes for survivors of out of hospital cardiac arrest: review and meta-analysis. Resuscitation 2014; 85:1533.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lemkes JS, Janssens GN, van der Hoeven NW, et al. Coronary Angiography after Cardiac Arrest without ST-Segment Elevation. N Engl J Med 2019; 380:1397.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lemkes JS, Janssens GN, van der Hoeven NW, et al. Coronary Angiography After Cardiac Arrest Without ST Segment Elevation: One-Year Outcomes of the COACT Randomized Clinical Trial. JAMA Cardiol 2020; 5:1358.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Desch S, Freund A, Akin I, et al. Angiography after Out-of-Hospital Cardiac Arrest without ST-Segment Elevation. N Engl J Med 2021; 385:2544.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Verma BR, Sharma V, Shekhar S, et al. Coronary Angiography in Patients With Out-of-Hospital Cardiac Arrest Without ST-Segment Elevation: A Systematic Review and Meta-Analysis. JACC Cardiovasc Interv 2020; 13:2193.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marra A, Ely EW, Pandharipande PP, Patel MB. The ABCDEF Bundle in Critical Care. Crit Care Clin 2017; 33:225.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hellyer TP, Ewan V, Wilson P, Simpson AJ. The Intensive Care Society recommended bundle of interventions for the prevention of ventilator-associated pneumonia. J Intensive Care Soc 2016; 17:238.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pun BT, Balas MC, Barnes-Daly MA, et al. Caring for Critically Ill Patients with the ABCDEF Bundle: Results of the ICU Liberation Collaborative in Over 15,000 Adults. Crit Care Med 2019; 47:3.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Longstreth WT Jr, Diehr P, Cobb LA, et al. Neurologic outcome and blood glucose levels during out-of-hospital cardiopulmonary resuscitation. Neurology 1986; 36:1186.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shin J, Kim K, Lim YS, et al. Incidence and clinical features of intracranial hemorrhage causing out-of-hospital cardiac arrest: a multicenter retrospective study. Am J Emerg Med 2016; 34:2326.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Borgquist O, Wise MP, Nielsen N, et al. Dysglycemia, Glycemic Variability, and Outcome After Cardiac Arrest and Temperature Management at 33°C and 36°C. Crit Care Med 2017; 45:1337.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           NICE-SUGAR Study Investigators, Finfer S, Chittock DR, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360:1283.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           NICE-SUGAR Study Investigators for the Australian and New Zealand Intensive Care Society Clinical Trials Group and the Canadian Critical Care Trials Group, Finfer S, Chittock D, et al. Intensive versus conventional glucose control in critically ill patients with traumatic brain injury: long-term follow-up of a subgroup of patients from the NICE-SUGAR study. Intensive Care Med 2015; 41:1037.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Luethi N, Cioccari L, Eastwood G, et al. Hospital-acquired complications in intensive care unit patients with diabetes: A before-and-after study of a conventional versus liberal glucose control protocol. Acta Anaesthesiol Scand 2019; 63:761.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ling Y, Li X, Gao X. Intensive versus conventional glucose control in critically ill patients: a meta-analysis of randomized controlled trials. Eur J Intern Med 2012; 23:564.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Callaway CW, Donnino MW, Fink EL, et al. Part 8: Post-Cardiac Arrest Care: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2015; 132:S465.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McKenzie N, Williams TA, Tohira H, et al. A systematic review and meta-analysis of the association between arterial carbon dioxide tension and outcomes after cardiac arrest. Resuscitation 2017; 111:116.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Buunk G, van der Hoeven JG, Frölich M, Meinders AE. Cerebral vasoconstriction in comatose patients resuscitated from a cardiac arrest? Intensive Care Med 1996; 22:1191.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Buunk G, van der Hoeven JG, Meinders AE. Cerebrovascular reactivity in comatose patients resuscitated from a cardiac arrest. Stroke 1997; 28:1569.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aufderheide TP, Lurie KG. Death by hyperventilation: a common and life-threatening problem during cardiopulmonary resuscitation. Crit Care Med 2004; 32:S345.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sitzwohl C, Kettner SC, Reinprecht A, et al. The arterial to end-tidal carbon dioxide gradient increases with uncorrected but not with temperature-corrected PaCO2 determination during mild to moderate hypothermia. Anesth Analg 1998; 86:1131.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schneider AG, Eastwood GM, Bellomo R, et al. Arterial carbon dioxide tension and outcome in patients admitted to the intensive care unit after cardiac arrest. Resuscitation 2013; 84:927.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vaahersalo J, Bendel S, Reinikainen M, et al. Arterial blood gas tensions after resuscitation from out-of-hospital cardiac arrest: associations with long-term neurologic outcome. Crit Care Med 2014; 42:1463.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eastwood GM, Tanaka A, Bellomo R. Cerebral oxygenation in mechanically ventilated early cardiac arrest survivors: The impact of hypercapnia. Resuscitation 2016; 102:11.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eastwood G, Nichol AD, Hodgson C, et al. Mild Hypercapnia or Normocapnia after Out-of-Hospital Cardiac Arrest. N Engl J Med 2023; 389:45.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang CH, Chang WT, Huang CH, et al. The effect of hyperoxia on survival following adult cardiac arrest: a systematic review and meta-analysis of observational studies. Resuscitation 2014; 85:1142.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schmidt H, Kjaergaard J, Hassager C, et al. Oxygen Targets in Comatose Survivors of Cardiac Arrest. N Engl J Med 2022; 387:1467.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gagnon DJ, Nielsen N, Fraser GL, et al. Prophylactic antibiotics are associated with a lower incidence of pneumonia in cardiac arrest survivors treated with targeted temperature management. Resuscitation 2015; 92:154.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Couper K, Laloo R, Field R, et al. Prophylactic antibiotic use following cardiac arrest: A systematic review and meta-analysis. Resuscitation 2019; 141:166.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002; 346:549.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee BK, Song KH, Jung YH, et al. The influence of post-rewarming temperature management on post-rewarming fever development after cardiac arrest. Resuscitation 2015; 97:20.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zeiner A, Holzer M, Sterz F, et al. Hyperthermia after cardiac arrest is associated with an unfavorable neurologic outcome. Arch Intern Med 2001; 161:2007.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gebhardt K, Guyette FX, Doshi AA, et al. Prevalence and effect of fever on outcome following resuscitation from cardiac arrest. Resuscitation 2013; 84:1062.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grossestreuer AV, Gaieski DF, Donnino MW, et al. Magnitude of temperature elevation is associated with neurologic and survival outcomes in resuscitated cardiac arrest patients with postrewarming pyrexia. J Crit Care 2017; 38:78.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lopez J, Cohn B. Does Intravascular Temperature Management Improve Outcomes Compared With Surface Cooling in Comatose Adults After Cardiac Arrest? Ann Emerg Med 2021; 77:589.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Keum KT, Kim YH, Lee JH, et al. Comparison of hydrogel pad and water-circulating blanket cooling methods for targeted temperature management: A propensity score-matched analysis from a prospective multicentre registry. Resuscitation 2021; 169:78.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ramadanov N, Arrich J, Klein R, et al. Intravascular Versus Surface Cooling in Patients Resuscitated From Cardiac Arrest: A Systematic Review and Network Meta-Analysis With Focus on Temperature Feedback. Crit Care Med 2022; 50:999.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schwab S, Schwarz S, Spranger M, et al. Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction. Stroke 1998; 29:2461.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schwab S, Georgiadis D, Berrouschot J, et al. Feasibility and safety of moderate hypothermia after massive hemispheric infarction. Stroke 2001; 32:2033.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nutma S, Tjepkema-Cloostermans MC, Ruijter BJ, et al. Effects of targeted temperature management at 33 °C vs. 36 °C on comatose patients after cardiac arrest stratified by the severity of encephalopathy. Resuscitation 2022; 173:147.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sadaka F, Veremakis C. Therapeutic hypothermia for the management of intracranial hypertension in severe traumatic brain injury: a systematic review. Brain Inj 2012; 26:899.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dunkley S, McLeod A. Therapeutic hypothermia in patients following traumatic brain injury: a systematic review. Nurs Crit Care 2017; 22:150.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Seule MA, Muroi C, Mink S, et al. Therapeutic hypothermia in patients with aneurysmal subarachnoid hemorrhage, refractory intracranial hypertension, or cerebral vasospasm. Neurosurgery 2009; 64:86.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stravitz RT, Larsen FS. Therapeutic hypothermia for acute liver failure. Crit Care Med 2009; 37:S258.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dmello D, Cruz-Flores S, Matuschak GM. Moderate hypothermia with intracranial pressure monitoring as a therapeutic paradigm for the management of acute liver failure: a systematic review. Intensive Care Med 2010; 36:210.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002; 346:557.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nielsen N, Wetterslev J, Cronberg T, et al. Targeted temperature management at 33°C versus 36°C after cardiac arrest. N Engl J Med 2013; 369:2197.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vargas M, Servillo G, Sutherasan Y, et al. Effects of in-hospital low targeted temperature after out of hospital cardiac arrest: A systematic review with meta-analysis of randomized clinical trials. Resuscitation 2015; 91:8.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dankiewicz J, Cronberg T, Lilja G, et al. Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest. N Engl J Med 2021; 384:2283.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Elbadawi A, Sedhom R, Baig B, et al. Targeted Hypothermia vs Targeted Normothermia in Survivors of Cardiac Arrest: A Systematic Review and Meta-Analysis of Randomized Trials. Am J Med 2022; 135:626.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arrich J, Schütz N, Oppenauer J, et al. Hypothermia for neuroprotection in adults after cardiac arrest. Cochrane Database Syst Rev 2023; 5:CD004128.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fernando SM, Di Santo P, Sadeghirad B, et al. Targeted temperature management following out-of-hospital cardiac arrest: a systematic review and network meta-analysis of temperature targets. Intensive Care Med 2021; 47:1078.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Granfeldt A, Holmberg MJ, Nolan JP, et al. Temperature control after adult cardiac arrest: An updated systematic review and meta-analysis. Resuscitation 2023; 191:109928.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Le May M, Osborne C, Russo J, et al. Effect of Moderate vs Mild Therapeutic Hypothermia on Mortality and Neurologic Outcomes in Comatose Survivors of Out-of-Hospital Cardiac Arrest: The CAPITAL CHILL Randomized Clinical Trial. JAMA 2021; 326:1494.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sendelbach S, Hearst MO, Johnson PJ, et al. Effects of variation in temperature management on cerebral performance category scores in patients who received therapeutic hypothermia post cardiac arrest. Resuscitation 2012; 83:829.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wolff B, Machill K, Schumacher D, et al. Early achievement of mild therapeutic hypothermia and the neurologic outcome after cardiac arrest. Int J Cardiol 2009; 133:223.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mooney MR, Unger BT, Boland LL, et al. Therapeutic hypothermia after out-of-hospital cardiac arrest: evaluation of a regional system to increase access to cooling. Circulation 2011; 124:206.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Awad A, Taccone FS, Jonsson M, et al. Time to intra-arrest therapeutic hypothermia in out-of-hospital cardiac arrest patients and its association with neurologic outcome: a propensity matched sub-analysis of the PRINCESS trial. Intensive Care Med 2020; 46:1361.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bernard SA, Smith K, Cameron P, et al. Induction of therapeutic hypothermia by paramedics after resuscitation from out-of-hospital ventricular fibrillation cardiac arrest: a randomized controlled trial. Circulation 2010; 122:737.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coppler PJ, Marill KA, Okonkwo DO, et al. Concordance of Brain and Core Temperature in Comatose Patients After Cardiac Arrest. Ther Hypothermia Temp Manag 2016; 6:194.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Robinson J, Charlton J, Seal R, et al. Oesophageal, rectal, axillary, tympanic and pulmonary artery temperatures during cardiac surgery. Can J Anaesth 1998; 45:317.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Erickson RS, Kirklin SK. Comparison of ear-based, bladder, oral, and axillary methods for core temperature measurement. Crit Care Med 1993; 21:1528.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chamorro C, Borrallo JM, Romera MA, et al. Anesthesia and analgesia protocol during therapeutic hypothermia after cardiac arrest: a systematic review. Anesth Analg 2010; 110:1328.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Deakin CD, Nolan JP, Soar J, et al. European Resuscitation Council Guidelines for Resuscitation 2010 Section 4. Adult advanced life support. Resuscitation 2010; 81:1305.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pichon N, Amiel JB, François B, et al. Efficacy of and tolerance to mild induced hypothermia after out-of-hospital cardiac arrest using an endovascular cooling system. Crit Care 2007; 11:R71.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Heard KJ, Peberdy MA, Sayre MR, et al. A randomized controlled trial comparing the Arctic Sun to standard cooling for induction of hypothermia after cardiac arrest. Resuscitation 2010; 81:9.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hassager C, Schmidt H, Møller JE, et al. Duration of Device-Based Fever Prevention after Cardiac Arrest. N Engl J Med 2023; 388:888.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim F, Olsufka M, Longstreth WT Jr, et al. Pilot randomized clinical trial of prehospital induction of mild hypothermia in out-of-hospital cardiac arrest patients with a rapid infusion of 4 degrees C normal saline. Circulation 2007; 115:3064.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moore TM, Callaway CW, Hostler D. Core temperature cooling in healthy volunteers after rapid intravenous infusion of cold and room temperature saline solution. Ann Emerg Med 2008; 51:153.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hostler D, Northington WE, Callaway CW. High-dose diazepam facilitates core cooling during cold saline infusion in healthy volunteers. Appl Physiol Nutr Metab 2009; 34:582.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Badjatia N, Strongilis E, Gordon E, et al. Metabolic impact of shivering during therapeutic temperature modulation: the Bedside Shivering Assessment Scale. Stroke 2008; 39:3242.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Callaway CW, Elmer J, Guyette FX, et al. Dexmedetomidine Reduces Shivering during Mild Hypothermia in Waking Subjects. PLoS One 2015; 10:e0129709.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Michelson AD, MacGregor H, Barnard MR, et al. Reversible inhibition of human platelet activation by hypothermia in vivo and in vitro. Thromb Haemost 1994; 71:633.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reed RL 2nd, Bracey AW Jr, Hudson JD, et al. Hypothermia and blood coagulation: dissociation between enzyme activity and clotting factor levels. Circ Shock 1990; 32:141.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Valeri CR, Feingold H, Cassidy G, et al. Hypothermia-induced reversible platelet dysfunction. Ann Surg 1987; 205:175.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Vrij EL, Vogelaar PC, Goris M, et al. Platelet dynamics during natural and pharmacologically induced torpor and forced hypothermia. PLoS One 2014; 9:e93218.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jeppesen AN, Hvas AM, Duez CHV, et al. Prolonged targeted temperature management compromises thrombin generation: A randomised clinical trial. Resuscitation 2017; 118:126.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jarrah S, Dziodzio J, Lord C, et al. Surface cooling after cardiac arrest: effectiveness, skin safety, and adverse events in routine clinical practice. Neurocrit Care 2011; 14:382.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Polderman KH, Herold I. Therapeutic hypothermia and controlled normothermia in the intensive care unit: practical considerations, side effects, and cooling methods. Crit Care Med 2009; 37:1101.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Polderman KH, Peerdeman SM, Girbes AR. Hypophosphatemia and hypomagnesemia induced by cooling in patients with severe head injury. J Neurosurg 2001; 94:697.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cueni-Villoz N, Devigili A, Delodder F, et al. Increased blood glucose variability during therapeutic hypothermia and outcome after cardiac arrest. Crit Care Med 2011; 39:2225.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nielsen N, Hovdenes J, Nilsson F, et al. Outcome, timing and adverse events in therapeutic hypothermia after out-of-hospital cardiac arrest. Acta Anaesthesiol Scand 2009; 53:926.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arrich J, Holzer M, Havel C, et al. Hypothermia for neuroprotection in adults after cardiopulmonary resuscitation. Cochrane Database Syst Rev 2016; 2:CD004128.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Winther-Jensen M, Pellis T, Kuiper M, et al. Mortality and neurological outcome in the elderly after target temperature management for out-of-hospital cardiac arrest. Resuscitation 2015; 91:92.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cronberg T, Lilja G, Horn J, et al. Neurologic Function and Health-Related Quality of Life in Patients Following Targeted Temperature Management at 33°C vs 36°C After Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial. JAMA Neurol 2015; 72:634.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schenone AL, Cohen A, Patarroyo G, et al. Therapeutic hypothermia after cardiac arrest: A systematic review/meta-analysis exploring the impact of expanded criteria and targeted temperature. Resuscitation 2016; 108:102.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nichol G, Aufderheide TP, Eigel B, et al. Regional systems of care for out-of-hospital cardiac arrest: A policy statement from the American Heart Association. Circulation 2010; 121:709.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arrich J, European Resuscitation Council Hypothermia After Cardiac Arrest Registry Study Group. Clinical application of mild therapeutic hypothermia after cardiac arrest. Crit Care Med 2007; 35:1041.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bernard SA, Jones BM, Horne MK. Clinical trial of induced hypothermia in comatose survivors of out-of-hospital cardiac arrest. Ann Emerg Med 1997; 30:146.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Busch M, Soreide E, Lossius HM, et al. Rapid implementation of therapeutic hypothermia in comatose out-of-hospital cardiac arrest survivors. Acta Anaesthesiol Scand 2006; 50:1277.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Storm C, Steffen I, Schefold JC, et al. Mild therapeutic hypothermia shortens intensive care unit stay of survivors after out-of-hospital cardiac arrest compared to historical controls. Crit Care 2008; 12:R78.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rittenberger JC, Guyette FX, Tisherman SA, et al. Outcomes of a hospital-wide plan to improve care of comatose survivors of cardiac arrest. Resuscitation 2008; 79:198.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oddo M, Schaller MD, Feihl F, et al. From evidence to clinical practice: effective implementation of therapeutic hypothermia to improve patient outcome after cardiac arrest. Crit Care Med 2006; 34:1865.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Whitfield AM, Coote S, Ernest D. Induced hypothermia after out-of-hospital cardiac arrest: one hospital's experience. Crit Care Resusc 2009; 11:97.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Don CW, Longstreth WT Jr, Maynard C, et al. Active surface cooling protocol to induce mild therapeutic hypothermia after out-of-hospital cardiac arrest: a retrospective before-and-after comparison in a single hospital. Crit Care Med 2009; 37:3062.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dumas F, Grimaldi D, Zuber B, et al. Is hypothermia after cardiac arrest effective in both shockable and nonshockable patients?: insights from a large registry. Circulation 2011; 123:877.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Storm C, Nee J, Roser M, et al. Mild hypothermia treatment in patients resuscitated from non-shockable cardiac arrest. Emerg Med J 2012; 29:100.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vaahersalo J, Hiltunen P, Tiainen M, et al. Therapeutic hypothermia after out-of-hospital cardiac arrest in Finnish intensive care units: the FINNRESUSCI study. Intensive Care Med 2013; 39:826.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim YM, Yim HW, Jeong SH, et al. Does therapeutic hypothermia benefit adult cardiac arrest patients presenting with non-shockable initial rhythms?: A systematic review and meta-analysis of randomized and non-randomized studies. Resuscitation 2012; 83:188.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hachimi-Idrissi S, Corne L, Ebinger G, et al. Mild hypothermia induced by a helmet device: a clinical feasibility study. Resuscitation 2001; 51:275.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lascarrou JB, Merdji H, Le Gouge A, et al. Targeted Temperature Management for Cardiac Arrest with Nonshockable Rhythm. N Engl J Med 2019; 381:2327.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Blanc A, Colin G, Cariou A, et al. Targeted Temperature Management After In-Hospital Cardiac Arrest: An Ancillary Analysis of Targeted Temperature Management for Cardiac Arrest With Nonshockable Rhythm Trial Data. Chest 2022; 162:356.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Merchant RM, Topjian AA, Panchal AR, et al. Part 1: Executive Summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2020; 142:S337.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Laver S, Farrow C, Turner D, Nolan J. Mode of death after admission to an intensive care unit following cardiac arrest. Intensive Care Med 2004; 30:2126.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Knight WA, Hart KW, Adeoye OM, et al. The incidence of seizures in patients undergoing therapeutic hypothermia after resuscitation from cardiac arrest. Epilepsy Res 2013; 106:396.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chong DJ, Hirsch LJ. Which EEG patterns warrant treatment in the critically ill? Reviewing the evidence for treatment of periodic epileptiform discharges and related patterns. J Clin Neurophysiol 2005; 22:79.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jordan KG, Hirsch LJ. In nonconvulsive status epilepticus (NCSE), treat to burst-suppression: pro and con. Epilepsia 2006; 47 Suppl 1:41.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alvarez V, Sierra-Marcos A, Oddo M, Rossetti AO. Yield of intermittent versus continuous EEG in comatose survivors of cardiac arrest treated with hypothermia. Crit Care 2013; 17:R190.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lybeck A, Friberg H, Aneman A, et al. Prognostic significance of clinical seizures after cardiac arrest and target temperature management. Resuscitation 2017; 114:146.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Amorim E, Rittenberger JC, Baldwin ME, et al. Malignant EEG patterns in cardiac arrest patients treated with targeted temperature management who survive to hospital discharge. Resuscitation 2015; 90:127.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rittenberger JC, Popescu A, Brenner RP, et al. Frequency and timing of nonconvulsive status epilepticus in comatose post-cardiac arrest subjects treated with hypothermia. Neurocrit Care 2012; 16:114.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Youn CS, Callaway CW, Rittenberger JC, Post Cardiac Arrest Service. Combination of initial neurologic examination and continuous EEG to predict survival after cardiac arrest. Resuscitation 2015; 94:73.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Youn CS, Callaway CW, Rittenberger JC, Post Cardiac Arrest Service. Combination of initial neurologic examination, quantitative brain imaging and electroencephalography to predict outcome after cardiac arrest. Resuscitation 2017; 110:120.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hofmeijer J, Tjepkema-Cloostermans MC, Blans MJ, et al. Unstandardized treatment of electroencephalographic status epilepticus does not improve outcome of comatose patients after cardiac arrest. Front Neurol 2014; 5:39.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ruijter BJ, Keijzer HM, Tjepkema-Cloostermans MC, et al. Treating Rhythmic and Periodic EEG Patterns in Comatose Survivors of Cardiac Arrest. N Engl J Med 2022; 386:724.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Elmer J, Rittenberger JC, Faro J, et al. Clinically distinct electroencephalographic phenotypes of early myoclonus after cardiac arrest. Ann Neurol 2016; 80:175.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nutma S, Ruijter BJ, Beishuizen A, et al. Myoclonus in comatose patients with electrographic status epilepticus after cardiac arrest: Corresponding EEG patterns, effects of treatment and outcomes. Resuscitation 2023; 186:109745.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cha KC, Kim HI, Kim OH, et al. Echocardiographic patterns of postresuscitation myocardial dysfunction. Resuscitation 2018; 124:90.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yao Y, Johnson NJ, Perman SM, et al. Myocardial dysfunction after out-of-hospital cardiac arrest: predictors and prognostic implications. Intern Emerg Med 2018; 13:765.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koren O, Rozner E, Yosefia S, Turgeman Y. Therapeutic hypothermia after out of hospital cardiac arrest improve 1-year survival rate for selective patients. PLoS One 2020; 15:e0226956.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Adrie C, Cariou A, Mourvillier B, et al. Predicting survival with good neurological recovery at hospital admission after successful resuscitation of out-of-hospital cardiac arrest: the OHCA score. Eur Heart J 2006; 27:2840.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haukoos JS, Lewis RJ, Stratton SJ, Niemann JT. Is the ACLS score a valid prediction rule for survival after cardiac arrest? Acad Emerg Med 2003; 10:621.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oksanen T, Tiainen M, Skrifvars MB, et al. Predictive power of serum NSE and OHCA score regarding 6-month neurologic outcome after out-of-hospital ventricular fibrillation and therapeutic hypothermia. Resuscitation 2009; 80:165.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 127223 Version 32.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31992061" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33765189" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : European Resuscitation Council and European Society of Intensive Care Medicine guidelines 2021: post-resuscitation care.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35089409" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : ERC-ESICM guidelines on temperature control after cardiac arrest in adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1951130" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Sudden unexpected death in persons less than 40 years of age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9243146" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Out-of-hospital cardiac arrests of non-cardiac origin. Epidemiology and outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27984154" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Cardiac arrest in schools: Nationwide incidence, risk, and outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17118509" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Epidemiology, trends, and outcome of out-of-hospital cardiac arrest of non-cardiac origin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33606342" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Early head-to-pelvis computed tomography in out-of-hospital circulatory arrest without obvious etiology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35043689" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Prevalence and Patterns of Resuscitation-Associated Injury Detected by Head-to-Pelvis Computed Tomography After Successful Out-of-Hospital Cardiac Arrest Resuscitation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19866506" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Significance of arterial hypotension after resuscitation from cardiac arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24333351" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : The association between systolic blood pressure on arrival at hospital and outcome in adults surviving from out-of-hospital cardiac arrests of presumed cardiac aetiology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18990478" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Early arterial hypotension is common in the post-cardiac arrest syndrome and associated with increased in-hospital mortality.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19217200" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Early goal-directed hemodynamic optimization combined with therapeutic hypothermia in comatose survivors of out-of-hospital cardiac arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17258378" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Implementation of a standardised treatment protocol for post resuscitation care after out-of-hospital cardiac arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36027564" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Blood-Pressure Targets in Comatose Survivors of Cardiac Arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20200382" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Comparison of dopamine and norepinephrine in the treatment of shock.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29069037" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Dopamine versus norepinephrine in the treatment of cardiogenic shock: A PRISMA-compliant meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19321536" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Coronary angiography predicts improved outcome following cardiac arrest: propensity-adjusted analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25698668" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Angiographic findings and survival in patients undergoing coronary angiography due to sudden cardiac arrest in western Sweden.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27640933" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Patients without ST elevation after return of spontaneous circulation may benefit from emergent percutaneous intervention: A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20484098" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Immediate percutaneous coronary intervention is associated with better survival after out-of-hospital cardiac arrest: insights from the PROCAT (Parisian Region Out of hospital Cardiac ArresT) registry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25195073" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Cardiac catheterization is associated with superior outcomes for survivors of out of hospital cardiac arrest: review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30883057" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Coronary Angiography after Cardiac Arrest without ST-Segment Elevation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32876654" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Coronary Angiography After Cardiac Arrest Without ST Segment Elevation: One-Year Outcomes of the COACT Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34459570" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Angiography after Out-of-Hospital Cardiac Arrest without ST-Segment Elevation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33032706" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Coronary Angiography in Patients With Out-of-Hospital Cardiac Arrest Without ST-Segment Elevation: A Systematic Review and Meta-Analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28284292" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : The ABCDEF Bundle in Critical Care.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28979497" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : The Intensive Care Society recommended bundle of interventions for the prevention of ventilator-associated pneumonia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30339549" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Caring for Critically Ill Patients with the ABCDEF Bundle: Results of the ICU Liberation Collaborative in Over 15,000 Adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3748384" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Neurologic outcome and blood glucose levels during out-of-hospital cardiopulmonary resuscitation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27727067" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Incidence and clinical features of intracranial hemorrhage causing out-of-hospital cardiac arrest: a multicenter retrospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28708678" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Dysglycemia, Glycemic Variability, and Outcome After Cardiac Arrest and Temperature Management at 33°C and 36°C.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19318384" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Intensive versus conventional glucose control in critically ill patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26088909" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Intensive versus conventional glucose control in critically ill patients with traumatic brain injury: long-term follow-up of a subgroup of patients from the NICE-SUGAR study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30882892" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Hospital-acquired complications in intensive care unit patients with diabetes: A before-and-after study of a conventional versus liberal glucose control protocol.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22863436" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Intensive versus conventional glucose control in critically ill patients: a meta-analysis of randomized controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26472996" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Part 8: Post-Cardiac Arrest Care: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27697606" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : A systematic review and meta-analysis of the association between arterial carbon dioxide tension and outcomes after cardiac arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9120112" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Cerebral vasoconstriction in comatose patients resuscitated from a cardiac arrest?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9259750" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Cerebrovascular reactivity in comatose patients resuscitated from a cardiac arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15508657" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Death by hyperventilation: a common and life-threatening problem during cardiopulmonary resuscitation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9585311" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : The arterial to end-tidal carbon dioxide gradient increases with uncorrected but not with temperature-corrected PaCO2 determination during mild to moderate hypothermia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23454258" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Arterial carbon dioxide tension and outcome in patients admitted to the intensive care unit after cardiac arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24557423" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Arterial blood gas tensions after resuscitation from out-of-hospital cardiac arrest: associations with long-term neurologic outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26903288" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Cerebral oxygenation in mechanically ventilated early cardiac arrest survivors: The impact of hypercapnia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37318140" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Mild Hypercapnia or Normocapnia after Out-of-Hospital Cardiac Arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24892265" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : The effect of hyperoxia on survival following adult cardiac arrest: a systematic review and meta-analysis of observational studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36027567" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Oxygen Targets in Comatose Survivors of Cardiac Arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25680823" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Prophylactic antibiotics are associated with a lower incidence of pneumonia in cardiac arrest survivors treated with targeted temperature management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31085216" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Prophylactic antibiotic use following cardiac arrest: A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11856793" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26410566" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : The influence of post-rewarming temperature management on post-rewarming fever development after cardiac arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11525703" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Hyperthermia after cardiac arrest is associated with an unfavorable neurologic outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23619740" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Prevalence and effect of fever on outcome following resuscitation from cardiac arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27866109" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Magnitude of temperature elevation is associated with neurologic and survival outcomes in resuscitated cardiac arrest patients with postrewarming pyrexia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33583627" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Does Intravascular Temperature Management Improve Outcomes Compared With Surface Cooling in Comatose Adults After Cardiac Arrest?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34678333" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Comparison of hydrogel pad and water-circulating blanket cooling methods for targeted temperature management: A propensity score-matched analysis from a prospective multicentre registry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35089906" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Intravascular Versus Surface Cooling in Patients Resuscitated From Cardiac Arrest: A Systematic Review and Network Meta-Analysis With Focus on Temperature Feedback.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9836751" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11546893" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Feasibility and safety of moderate hypothermia after massive hemispheric infarction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35122892" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Effects of targeted temperature management at 33 °C vs. 36 °C on comatose patients after cardiac arrest stratified by the severity of encephalopathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22448655" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Therapeutic hypothermia for the management of intracranial hypertension in severe traumatic brain injury: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27150123" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Therapeutic hypothermia in patients following traumatic brain injury: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19050656" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Therapeutic hypothermia in patients with aneurysmal subarachnoid hemorrhage, refractory intracranial hypertension, or cerebral vasospasm.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19535956" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Therapeutic hypothermia for acute liver failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19847396" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Moderate hypothermia with intracranial pressure monitoring as a therapeutic paradigm for the management of acute liver failure: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11856794" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24237006" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Targeted temperature management at 33°C versus 36°C after cardiac arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25796995" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Effects of in-hospital low targeted temperature after out of hospital cardiac arrest: A systematic review with meta-analysis of randomized clinical trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34133859" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34958763" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Targeted Hypothermia vs Targeted Normothermia in Survivors of Cardiac Arrest: A Systematic Review and Meta-Analysis of Randomized Trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37217440" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Hypothermia for neuroprotection in adults after cardiac arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34389870" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Targeted temperature management following out-of-hospital cardiac arrest: a systematic review and network meta-analysis of temperature targets.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37558083" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Temperature control after adult cardiac arrest: An updated systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34665203" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Effect of Moderate vs Mild Therapeutic Hypothermia on Mortality and Neurologic Outcomes in Comatose Survivors of Out-of-Hospital Cardiac Arrest: The CAPITAL CHILL Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22230942" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Effects of variation in temperature management on cerebral performance category scores in patients who received therapeutic hypothermia post cardiac arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18353458" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Early achievement of mild therapeutic hypothermia and the neurologic outcome after cardiac arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21747066" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Therapeutic hypothermia after out-of-hospital cardiac arrest: evaluation of a regional system to increase access to cooling.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32514590" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Time to intra-arrest therapeutic hypothermia in out-of-hospital cardiac arrest patients and its association with neurologic outcome: a propensity matched sub-analysis of the PRINCESS trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20679551" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Induction of therapeutic hypothermia by paramedics after resuscitation from out-of-hospital ventricular fibrillation cardiac arrest: a randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27249337" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Concordance of Brain and Core Temperature in Comatose Patients After Cardiac Arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9597204" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Oesophageal, rectal, axillary, tympanic and pulmonary artery temperatures during cardiac surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8403963" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Comparison of ear-based, bladder, oral, and axillary methods for core temperature measurement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20418296" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Anesthesia and analgesia protocol during therapeutic hypothermia after cardiac arrest: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20956049" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : European Resuscitation Council Guidelines for Resuscitation 2010 Section 4. Adult advanced life support.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17598898" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Efficacy of and tolerance to mild induced hypothermia after out-of-hospital cardiac arrest using an endovascular cooling system.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19854555" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : A randomized controlled trial comparing the Arctic Sun to standard cooling for induction of hypothermia after cardiac arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36342119" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Duration of Device-Based Fever Prevention after Cardiac Arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17548731" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Pilot randomized clinical trial of prehospital induction of mild hypothermia in out-of-hospital cardiac arrest patients with a rapid infusion of 4 degrees C normal saline.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18045737" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Core temperature cooling in healthy volunteers after rapid intravenous infusion of cold and room temperature saline solution.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19767791" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : High-dose diazepam facilitates core cooling during cold saline infusion in healthy volunteers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18927450" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Metabolic impact of shivering during therapeutic temperature modulation: the Bedside Shivering Assessment Scale.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26237219" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Dexmedetomidine Reduces Shivering during Mild Hypothermia in Waking Subjects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7522354" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Reversible inhibition of human platelet activation by hypothermia in vivo and in vitro.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2253317" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Hypothermia and blood coagulation: dissociation between enzyme activity and clotting factor levels.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3813688" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Hypothermia-induced reversible platelet dysfunction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24722364" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Platelet dynamics during natural and pharmacologically induced torpor and forced hypothermia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28602694" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Prolonged targeted temperature management compromises thrombin generation: A randomised clinical trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21249528" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Surface cooling after cardiac arrest: effectiveness, skin safety, and adverse events in routine clinical practice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19237924" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Therapeutic hypothermia and controlled normothermia in the intensive care unit: practical considerations, side effects, and cooling methods.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11354399" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Hypophosphatemia and hypomagnesemia induced by cooling in patients with severe head injury.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21705888" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Increased blood glucose variability during therapeutic hypothermia and outcome after cardiac arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19549271" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Outcome, timing and adverse events in therapeutic hypothermia after out-of-hospital cardiac arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26878327" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Hypothermia for neuroprotection in adults after cardiopulmonary resuscitation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25597506" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Mortality and neurological outcome in the elderly after target temperature management for out-of-hospital cardiac arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25844993" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Neurologic Function and Health-Related Quality of Life in Patients Following Targeted Temperature Management at 33°C vs 36°C After Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27521472" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Therapeutic hypothermia after cardiac arrest: A systematic review/meta-analysis exploring the impact of expanded criteria and targeted temperature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20075331" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Regional systems of care for out-of-hospital cardiac arrest: A policy statement from the American Heart Association.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17334257" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : Clinical application of mild therapeutic hypothermia after cardiac arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9250636" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : Clinical trial of induced hypothermia in comatose survivors of out-of-hospital cardiac arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17067329" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : Rapid implementation of therapeutic hypothermia in comatose out-of-hospital cardiac arrest survivors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18554414" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : Mild therapeutic hypothermia shortens intensive care unit stay of survivors after out-of-hospital cardiac arrest compared to historical controls.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18951113" id="rid112" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          113 : Outcomes of a hospital-wide plan to improve care of comatose survivors of cardiac arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16715035" id="rid113" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          114 : From evidence to clinical practice: effective implementation of therapeutic hypothermia to improve patient outcome after cardiac arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19485872" id="rid114" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          115 : Induced hypothermia after out-of-hospital cardiac arrest: one hospital's experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19770738" id="rid115" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          116 : Active surface cooling protocol to induce mild therapeutic hypothermia after out-of-hospital cardiac arrest: a retrospective before-and-after comparison in a single hospital.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21321156" id="rid116" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          117 : Is hypothermia after cardiac arrest effective in both shockable and nonshockable patients?: insights from a large registry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21362725" id="rid117" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          118 : Mild hypothermia treatment in patients resuscitated from non-shockable cardiac arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23417209" id="rid118" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          119 : Therapeutic hypothermia after out-of-hospital cardiac arrest in Finnish intensive care units: the FINNRESUSCI study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21835145" id="rid119" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          120 : Does therapeutic hypothermia benefit adult cardiac arrest patients presenting with non-shockable initial rhythms?: A systematic review and meta-analysis of randomized and non-randomized studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11738778" id="rid120" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          121 : Mild hypothermia induced by a helmet device: a clinical feasibility study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31577396" id="rid121" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          122 : Targeted Temperature Management for Cardiac Arrest with Nonshockable Rhythm.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35318006" id="rid122" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          123 : Targeted Temperature Management After In-Hospital Cardiac Arrest: An Ancillary Analysis of Targeted Temperature Management for Cardiac Arrest With Nonshockable Rhythm Trial Data.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33081530" id="rid123" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          124 : Part 1: Executive Summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15365608" id="rid124" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          125 : Mode of death after admission to an intensive care unit following cardiac arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23906560" id="rid125" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          126 : The incidence of seizures in patients undergoing therapeutic hypothermia after resuscitation from cardiac arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15805807" id="rid126" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          127 : Which EEG patterns warrant treatment in the critically ill? Reviewing the evidence for treatment of periodic epileptiform discharges and related patterns.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17044825" id="rid127" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          128 : In nonconvulsive status epilepticus (NCSE), treat to burst-suppression: pro and con.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24007625" id="rid128" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          129 : Yield of intermittent versus continuous EEG in comatose survivors of cardiac arrest treated with hypothermia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28163232" id="rid129" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          130 : Prognostic significance of clinical seizures after cardiac arrest and target temperature management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25779006" id="rid130" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          131 : Malignant EEG patterns in cardiac arrest patients treated with targeted temperature management who survive to hospital discharge.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21638118" id="rid131" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          132 : Frequency and timing of nonconvulsive status epilepticus in comatose post-cardiac arrest subjects treated with hypothermia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26164682" id="rid132" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          133 : Combination of initial neurologic examination and continuous EEG to predict survival after cardiac arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27840004" id="rid133" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          134 : Combination of initial neurologic examination, quantitative brain imaging and electroencephalography to predict outcome after cardiac arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24744748" id="rid134" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          135 : Unstandardized treatment of electroencephalographic status epilepticus does not improve outcome of comatose patients after cardiac arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35196426" id="rid135" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          136 : Treating Rhythmic and Periodic EEG Patterns in Comatose Survivors of Cardiac Arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27351833" id="rid136" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          137 : Clinically distinct electroencephalographic phenotypes of early myoclonus after cardiac arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36822459" id="rid137" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          138 : Myoclonus in comatose patients with electrographic status epilepticus after cardiac arrest: Corresponding EEG patterns, effects of treatment and outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29331650" id="rid138" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          139 : Echocardiographic patterns of postresuscitation myocardial dysfunction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28983759" id="rid139" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          140 : Myocardial dysfunction after out-of-hospital cardiac arrest: predictors and prognostic implications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31910226" id="rid140" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          141 : Therapeutic hypothermia after out of hospital cardiac arrest improve 1-year survival rate for selective patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17082207" id="rid141" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          142 : Predicting survival with good neurological recovery at hospital admission after successful resuscitation of out-of-hospital cardiac arrest: the OHCA score.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12782522" id="rid142" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          143 : Is the ACLS score a valid prediction rule for survival after cardiac arrest?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18954930" id="rid143" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          144 : Predictive power of serum NSE and OHCA score regarding 6-month neurologic outcome after out-of-hospital ventricular fibrillation and therapeutic hypothermia.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
